Coronary atherosclerosis

I9_CORATHER

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — I24, I25, T82.2, Z95.1 Hospital discharge: ICD-9 — 414\|9960A Hospital discharge: ICD-8 — 414 Hospital discharge: excluded ICD-10 — I25.3 Cause of death: ICD-10 — I24, I25, T82.2, Z95.1 Cause of death: ICD-9 — 414\|9960A Cause of death: ICD-8 — 414 Cause of death: excluded ICD-10 — I25.3 2 out of 7 registries used, show all original rules.	68960
4. Check minimum number of events None	68960
5. Include endpoints None	68960
6. Filter based on genotype QC (FinnGen only)	67091

Control definitions (FinnGen only)

Control exclude: I9_ISCHHEART

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2

NAME	I9_CORATHER
CONTROL_EXCLUDE	I9_ISCHHEART
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	I25\|I24\|Z951\|T822
HD_ICD_9	414\|9960A
HD_ICD_8	414
HD_ICD_10_EXCL	I253
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	I25\|I24\|Z951\|T822
COD_ICD_9	414\|9960A
COD_ICD_8	414
COD_ICD_10_EXCL	I253
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Coronary atherosclerosis based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	657584	279386	367876
Only index persons	436363	184909	251454
Unadjusted period prevalence (%)
Whole population	9.32	8.00	10.28
Only index persons	8.41	6.80	9.60
Median age at first event (years)
Whole population	72.88	77.44	69.41
Only index persons	71.32	76.17	67.74

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	67091	21401	45690
Unadjusted period prevalence (%)	16.68	7.59	20.93
Median age at first event (years)	68.80	70.29	68.10

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
34868: Matched controls
220543

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

FWD00

NOMESCO Finland

Reoperation for superficial haemorrhage in surgery of heart and major thoracic vessels

41.3

323.3

285

I70.9

ICD-10 Finland

Generalized and unspecified atherosclerosis

6.3

322.8

669

682

FM1CR

NOMESCO Finland

Heart perfusion PET with TT

122.5

321.6

250

4120B

ICD-9 Finland

Old myocardial infarction[STATUS POST INFARCTUM CORDIS,AHTAUTUNUT]

+∞

320.7

370

111

Conventional CABG

+∞

317.2

366

XFN00

NOMESCO Finland

Inside imaging of coronary arteries??

63.5

313.7

259

R55

ICD-10 Finland

Syncope and collapse

2.1

313.2

3756

12128

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

3.3

309.6

1395

2763

B04AB02, ,

ATC

5.9

308.8

675

730

FC1AC

NOMESCO Finland

Angiography of thoracal aortta

72.7

308.8

251

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

3.8

307.7

5366

10157

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

3.1

307.7

4849

10794

C10AA02

ATC

lovastatin; oral

3.4

307.7

1512

2880

FN1BT

NOMESCO Finland

Extensive endovascular dilatation of coronary (PTCA) arteries

+∞

307.7

1801

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

4.2

307.7

1561

2425

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

79.4

307.7

2669

230

AN2

Balloon angioplasty, including several vessels

+∞

307.7

1743

FMD10

NOMESCO Finland

Replacement of aortic valve using biological prosthesis

74.7

307.7

592

R07.3

ICD-10 Finland

Other chest pain

3.0

307.7

4184

9524

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

4.6

307.7

4615

7145

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

3.9

307.7

1580

2653

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

4.5

307.7

9143

15983

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

+∞

307.7

7618

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

2.5

307.7

5971

16622

C09AA02

ATC

enalapril; systemic

1.9

307.7

7270

26765

C10AA05

ATC

atorvastatin; oral

4.7

307.7

22612

61896

FN1BE

NOMESCO Finland

Ultrasound examination of coronary arteries through catheter

+∞

307.7

563

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

3.4

307.7

1710

3280

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.2

307.7

3652

11027

I34.00

ICD-10 Finland

Mitral (valve) incompetence NOS or of specified cause, except rheumatic

6.5

307.7

710

706

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

4120.9

307.7

3558

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.7

307.7

19572

70084

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

3.9

307.7

1496

2528

C10AX09

ATC

ezetimibe; oral

7.6

307.7

12152

14424

A10AB05

ATC

insulin aspart; parenteral

3.2

307.7

3241

6839

WX872

NOMESCO Finland

Intensive care

8.3

307.7

3045

2513

FNC30

NOMESCO Finland

Aorto-coronary venous bypass with three distal anastomoses

+∞

307.7

1119

B01AF02

ATC

apixaban; oral

2.2

307.7

4693

14555

A10AB01

ATC

insulin (human); parenteral

4.5

307.7

1364

1970

B01AC06

ATC

acetylsalicylic acid; oral

53.9

307.7

1494

183

ZXD00

NOMESCO Finland

Emergency procedure

6.4

307.7

1310

1347

FXZ00

NOMESCO Finland

Off-pump cardiac operation

204.5

307.7

352

I35.0

ICD-10 Finland

Aortic (valve) stenosis

5.4

307.7

2635

3289

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

1250.4

307.7

3710

FN1BB

NOMESCO Finland

Contrast angiography of heart and/or coronary arteries after bypass surgery

+∞

307.7

660

TFC10

NOMESCO Finland

Catheterisation of left atrium or ventricle

88.5

307.7

686

FNC40

NOMESCO Finland

Aorto-coronary venous bypass with four distal anastomoses

+∞

307.7

424

C08CA07

ATC

nisoldipine; oral

15.1

307.7

460

195

B01AC24

ATC

ticagrelor; oral

2208.8

307.7

4288

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

12.7

307.7

445

225

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

5.1

307.7

2699

3541

I21.99

ICD-10 Finland

Myocardial infarction (acute) UNS unspecified coronary artery status

1183.2

307.7

1560

C10AX13

ATC

evolocumab; parenteral

41.8

307.7

444

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

27.6

307.7

22244

13218

A11

ICPC

Chest pain NOS

3.5

307.7

3654

7095

AA1

Conventional CABG

+∞

307.7

1275

C09AA05

ATC

ramipril; oral

4.1

307.7

13512

29784

I21.10

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

+∞

307.7

562

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

5.2

307.7

854

1064

C10AA07

ATC

rosuvastatin; oral

2.5

307.7

14302

47620

103

Kela drug reimbursment

Diabetes, insulin-treated

2.5

307.7

11752

37873

B01AC22

ATC

prasugrel; oral

98.5

307.7

324

I21.9

ICD-10 Finland

Acute myocardial infarction, unspecified

318.9

307.7

546

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

241.5

307.7

9492

341

AP1

Catheterization of the left side of the heart

142.5

307.7

900

I50.0

ICD-10 Finland

Congestive heart failure

6.4

307.7

3642

3943

I20.8

ICD-10 Finland

Other forms of angina pectoris

68.3

307.7

374

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

2.4

307.7

10367

32821

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.3

307.7

3661

10631

I47.2

ICD-10 Finland

Ventricular tachycardia

9.7

307.7

892

596

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

2.5

307.7

10788

33374

PEF23

NOMESCO Finland

Thrombendarterectomy of femoral artery

6.5

307.7

748

736

SPAT1262

SPAT

Handing over of treatment supplies

1.9

307.7

6444

23064

FL1AC

NOMESCO Finland

Left cardioangiography

611.7

307.7

941

A10AA02, ,

ATC

4.7

307.7

1340

1860

FN1CC

NOMESCO Finland

Very extensive angiography of heart and/or coronary arteries

22.3

307.7

794

230

R07.2

ICD-10 Finland

Precordial pain

5.7

307.7

930

1048

A10BH01

ATC

sitagliptin; oral

2.2

307.7

3637

11210

250, ,

Kela drug reimbursment

13.2

307.7

648

315

C08CA01

ATC

amlodipine; oral

2.1

307.7

15705

61855

FN2AB

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), drug-eluting balloon

+∞

307.7

1625

C07AB02

ATC

metoprolol; systemic

3.3

307.7

9252

21529

AN3

Balloon angioplasty and metallic stent

+∞

307.7

2163

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

42.9

307.7

627

C07AG02

ATC

carvedilol; oral

2.7

307.7

2211

5491

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

196.6

307.7

2802

N02AX02

ATC

tramadol; systemic, rectal

1.7

307.7

15352

70355

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1940.8

307.7

30592

810

FN1XT

NOMESCO Finland

Other coronary artery procedure through catheter

+∞

307.7

404

I25.5

ICD-10 Finland

Ischaemic cardiomyopathy

638.6

307.7

1171

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.1

307.7

6639

21908

Angiography of the heart and coronary arteries

63.6

307.7

4145

467

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.7

307.7

8471

34539

K76

ICPC

Ischaemic heart dis without angina

64.9

307.7

2048

212

C01BD01

ATC

amiodarone; systemic

6.9

307.7

1298

1236

I20

ICD-10 Finland

Angina pectoris

18.2

307.7

827

294

C03CA01

ATC

furosemide; systemic

3.6

307.7

14432

36078

WX720

NOMESCO Finland

Own respiration

3.0

307.7

1707

3720

A12BA01

ATC

potassium chloride; oral

3.2

307.7

1554

3199

A10AC01

ATC

insulin (human); parenteral

3.7

307.7

3131

5706

I20.90

ICD-10 Finland

Angina pectoris, unspecified

357.2

307.7

2072

C01AA05

ATC

digoxin; systemic

3.4

307.7

2997

6015

I20.0

ICD-10 Finland

Unstable angina

42.9

307.7

488

TK800

NOMESCO Finland

Hemodialysis

4.8

307.7

951

1277

SPAT1097

SPAT

Recording of ECG

2.1

307.7

5431

17499

ZXE00

NOMESCO Finland

One hour or less

1.6

307.7

12414

55538

I25

ICD-10 Finland

Chronic ischaemic heart disease

93.8

307.7

4364

336

I21.11

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

+∞

307.7

1331

I35.2

ICD-10 Finland

Aortic (valve) stenosis with insufficiency

5.4

307.7

917

1103

I21.00

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

4772.5

307.7

745

4130X

ICD-9 Finland

Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),MÄÄRITTELEMÄT]

+∞

307.7

592

FN2CC

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA) of left main trunk

+∞

307.7

544

A10AE04

ATC

insulin glargine; parenteral

3.0

307.7

4235

9731

C10AA03

ATC

pravastatin; oral

3.4

307.7

3355

6659

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

10.4

307.7

12877

11754

XF400

NOMESCO Finland

ECG with 12 standard connections

2.7

307.7

6600

17705

K84

ICPC

Heart disease other

10.4

307.7

1543

975

WX892

NOMESCO Finland

Monitored bed care

3.3

307.7

3198

6589

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

224.7

307.7

5533

185

280

Kela drug reimbursment

Clopidogrel

538.2

307.7

992

C03DA01

ATC

spironolactone; oral

3.8

307.7

5670

10695

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

4.0

307.7

1261

2037

XF404

NOMESCO Finland

Ambulatory ECG

3.4

307.7

3735

7620

I21.40

ICD-10 Finland

Acute subendocardial infarction no detected stenosis of the coronary artery

2704.9

307.7

1657

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

4503599627370496.0

307.7

4638

I20.09

ICD-10 Finland

Unstable angina

381.5

307.7

4699

I21.19

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

+∞

307.7

976

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

7151.2

307.7

7249

K01

ICPC

Heart pain

7.7

307.7

615

511

I20.91

ICD-10 Finland

Angina pectoris, unspecified

769.7

307.7

832

C10AA01

ATC

simvastatin; oral

3.5

307.7

20749

64678

A10BB12

ATC

glimepiride; oral

2.8

307.7

2646

6359

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

15.4

307.7

1980

859

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.7

307.7

9357

38926

FME20

NOMESCO Finland

Transvenous aortic valve replacement via femoral artery

53.7

307.7

403

B01AC04

ATC

clopidogrel; oral

14.0

307.7

14142

10237

FN2AA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), balloon only

+∞

307.7

627

A10AA01, ,

ATC

4.7

307.7

1021

1416

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

5.6

307.7

1684

1966

A02BC02

ATC

pantoprazole; systemic

1.9

307.7

24156

119561

R06.0

ICD-10 Finland

Dyspnoea

3.0

307.7

11387

30867

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

6.5

307.7

1162

1157

I50.1

ICD-10 Finland

Left ventricular failure

13.3

307.7

2800

1442

C10AA04

ATC

fluvastatin; oral

3.1

307.7

3929

8558

K74

ICPC

Ischaemic heart dis with angina

40.7

307.7

903

144

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

3.2

307.7

1996

4102

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

3.7

307.7

4223

7958

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

6.8

307.7

3455

3506

K77

ICPC

Heart failure

5.3

307.7

809

978

XF402

NOMESCO Finland

ECG with work load test

5.3

307.7

6253

8718

AA1AD

NOMESCO Finland

CT of head and brain

1.8

307.7

9790

39437

I20.9

ICD-10 Finland

Angina pectoris, unspecified

25.8

307.7

669

167

FN2CB

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA) of coronary chronic total occlusion

+∞

307.7

566

I21.09

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

2304.2

307.7

1079

4100X

ICD-9 Finland

Acute myocardial infarction, Of anterolateral wall[INFARCTUS MYOCARDII ACUTUS DEFINITUS,MÄÄRITTELEMÄT]

+∞

307.7

693

FN1AT

NOMESCO Finland

Endovascular dilatation of coronary arteries (PTCA)

+∞

307.7

4145

I49.5

ICD-10 Finland

Sick sinus syndrome

3.7

307.7

1353

2354

FN2CA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), treating more than one main trunk during a single procedure

+∞

307.7

1122

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

35.4

307.7

959

176

Catheterization and pressure measurement of the left side of the heart

54.7

307.7

770

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

6.1

307.7

2156

2349

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

112.6

307.7

5356

355

4130B

ICD-9 Finland

Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),AHTAUTUNUT]

+∞

307.7

608

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

2.6

307.7

6733

18686

TFP20

NOMESCO Finland

Cardiodefibrillation

2.8

307.7

2745

6440

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

24.5

307.7

1005

267

207

Kela drug reimbursment

Chronic arrhythmias

3.0

307.7

6852

16678

I20.00

ICD-10 Finland

Unstable angina

958.5

307.7

2000

B01AC07

ATC

dipyridamole; systemic

3.4

307.7

1498

2866

AN1

Coronary angiography

314.1

307.7

10026

283

I42.9

ICD-10 Finland

Cardiomyopathy, unspecified

9.0

307.7

581

413

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

3.3

307.7

1860

3732

R02

ICPC

Shortness of breath/dyspnoea

2.3

307.7

4539

13544

I21.90

ICD-10 Finland

Myocardial infarction (acute) UNS no detected stenosis of the coronary artery

2789.1

307.7

873

B01AA03

ATC

warfarin; systemic

3.3

307.7

8339

19362

A10AE05

ATC

insulin detemir; parenteral

3.4

307.7

2153

4239

C09DX04

ATC

valsartan and sacubitril; oral

46.6

307.7

537

Single vessel balloon catheter extension

+∞

307.7

1448

FNE20

NOMESCO Finland

Coronary bypass using free arterial graft of radial artery

+∞

307.7

449

XFE00

NOMESCO Finland

Epicardial ultrasonography

5.6

307.7

927

1074

I48

ICD-10 Finland

Atrial fibrillation and flutter

2.8

307.7

9329

25097

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.8

307.7

10351

41799

TPH04

NOMESCO Finland

Cathetrisation of vein

1.9

307.7

7778

28772

I20.99

ICD-10 Finland

Angina pectoris, unspecified

191.5

307.7

4987

192

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

+∞

307.7

3794

289

Kela drug reimbursment

Combination product containing sacubitril and valsartan

46.9

307.7

547

I50

ICD-10 Finland

Heart failure

4.3

307.7

1103

1655

TPH07

NOMESCO Finland

Cathetrisation of artery

3.1

307.7

5141

11571

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

3.4

307.7

2864

5684

I46.0

ICD-10 Finland

Cardiac arrest with successful resuscitation

11.7

307.7

718

394

A10AB04

ATC

insulin lispro; parenteral

4.0

307.7

1156

1855

4120X

ICD-9 Finland

Old myocardial infarction[STATUS POST INFARCTUM CORDIS,MÄÄRITTELEMÄT]

+∞

307.7

384

A10BA02

ATC

metformin; oral

2.2

307.7

11533

41003

A10BK01

ATC

dapagliflozin; oral

2.4

307.7

2707

7344

PD5AD

NOMESCO Finland

CT of aorta

5.2

307.7

838

1035

AN4

Balloon angioplasty and drug eluding stent

+∞

307.7

3120

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

4.4

307.7

1067

1584

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

2.4

307.7

3077

8438

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

+∞

307.7

23387

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

+∞

307.7

5068

C01DA14

ATC

isosorbide mononitrate; oral

40.4

307.7

14011

3606

R07.4

ICD-10 Finland

Chest pain, unspecified

4.9

307.7

15189

29766

M04AA01

ATC

allopurinol; systemic

2.2

307.7

4986

15525

Coronary artery bypass surgery

+∞

307.7

1118

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.3

307.7

2644

5336

Z50.0

ICD-10 Finland

Cardiac rehabilitation

116.2

307.7

755

T90

ICPC

Diabetes non-insulin dependent

2.1

307.7

9731

34561

FPG32

NOMESCO Finland

Implantation of cardioverter-defibrillator with atrial and ventricular electrodes

28.2

307.7

327

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.9

307.7

10052

38945

381

Kela drug reimbursment

Combination product containing sacubitril and valsartan

46.3

307.7

491

205

Kela drug reimbursment

Chronic hypertension

2.3

307.7

11448

38825

FN1CB

NOMESCO Finland

Coronary flow reserve measurement with pressure wire

16384.0

307.7

2864

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.9

307.7

5608

20026

I50.9

ICD-10 Finland

Heart failure, unspecified

5.5

307.7

7212

10070

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

+∞

307.7

4061

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

5.4

307.7

10427

16256

201

Kela drug reimbursment

Chronic cardiac insufficiency

10.3

307.7

2793

1855

FN1AD

NOMESCO Finland

CT of coronary arteries

+∞

307.7

888

I20.80

ICD-10 Finland

Other angina pectoris no detected stenosis of coronary artery

530.5

307.7

819

294

Kela drug reimbursment

Alirocumab and evolocumab for the treatment of hypercholesterolaemia and dyslipidaemia

285.7

307.7

446

A10BK03

ATC

empagliflozin; oral

2.6

307.7

4063

10461

I21.4

ICD-10 Finland

Acute subendocardial myocardial infarction

337.1

307.7

525

I20.01

ICD-10 Finland

Unstable angina

3563.7

307.7

2641

ANC

Coronary artery pressure measurement (FFR, fractional flow reserve)

31.1

307.7

505

104

FNC20

NOMESCO Finland

Aorto-coronary venous bypass with two distal anastomoses

+∞

307.7

1563

K78

ICPC

Atrial fibrillation/flutter

2.5

307.7

2712

7214

I42.0

ICD-10 Finland

Dilated cardiomyopathy

10.2

307.7

1128

721

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

280.7

307.7

20736

1147

FNC10

NOMESCO Finland

Aorto-coronary venous bypass with single distal anastomosis

+∞

307.7

980

I10

ICD-10 Finland

Essential (primary) hypertension

2.5

307.7

24878

109529

ZXE20

NOMESCO Finland

More than three and less than five hours

2.1

307.7

4807

15419

3015

Kela drug reimbursment

Alirocumab and evolocumab for the treatment of hypercholesterolaemia and dyslipidaemia

65.6

307.7

471

FPG30

NOMESCO Finland

Implantation of cardioverter-defibrillator with ventricular electrode

98.5

307.7

324

I25.8

ICD-10 Finland

Other forms of chronic ischaemic heart disease

620.7

307.7

862

FN1CA

NOMESCO Finland

Optical coherence tomography of coronary arteries

+∞

307.7

517

I21.21

ICD-10 Finland

Acute transmural myocardial infarction with another location stenosed coronary artery

+∞

307.7

381

I21.97

ICD-10 Finland

Suspected acute myocardial infarction

63.2

307.7

483

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

5.6

307.7

13303

22034

I21.01

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

+∞

307.7

1496

I24.9

ICD-10 Finland

Acute ischaemic heart disease, unspecified

177.9

307.7

279

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

3.0

307.7

2427

5358

C07AB07

ATC

bisoprolol; oral

6.7

307.7

25962

66755

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

1833.6

307.7

4757

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

4.0

307.7

1873

3066

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

5.6

307.7

2923

3517

215

Kela drug reimbursment

Diabetes, non-insulin-treated

2.3

307.7

10439

35104

C08DB01

ATC

diltiazem; oral

3.7

307.7

2112

3764

TFP00

NOMESCO Finland

Temporary use of transvenous or epicardial pacemaker

15.0

307.7

443

189

ZXD05

NOMESCO Finland

Urgent procedure

2.7

307.7

11822

35144

I25.2

ICD-10 Finland

Old myocardial infarction

1608.4

307.7

6430

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.4

306.8

2609

7298

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

4.4

306.5

920

1348

H3603, E103,

ICD-10 Finland

8.8

300.5

478

346

R4110

NOMESCO Finland

Physiotherapy

1.6

299.2

9261

40010

5315

FHL

Bypass surgery using a mammary artery

+∞

298.1

344

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.3

297.4

2644

7542

R03BB04

ATC

tiotropium bromide; inhalant

2.1

297.0

3555

11457

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.6

294.7

10858

48907

FMD00

NOMESCO Finland

Replacement of aortic valve using mechanical prosthesis

21.5

293.7

304

I21.39

ICD-10 Finland

Acute transmural myocardial infarction with unspecified localization unspecified coronary artery status

1128.9

292.6

343

A10BB01

ATC

glibenclamide; oral

3.2

291.6

1341

2690

C08CA13

ATC

lercanidipine; oral

1.8

289.5

5214

19336

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

4.2

289.4

908

1380

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.9

287.5

4689

16843

I49.0

ICD-10 Finland

Ventricular fibrillation and flutter

12.7

286.3

368

185

R03AC02

ATC

salbutamol; inhalant

1.5

284.2

16806

83890

C08CA02

ATC

felodipine; oral

2.1

283.0

3432

11104

K92

ICPC

Atherosclerosis/periph vascular dis

6.0

282.9

610

650

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.8

282.3

5671

21725

I44.2

ICD-10 Finland

Atrioventricular block, complete

4.2

280.7

901

1395

I65.2

ICD-10 Finland

Occlusion and stenosis of carotid artery

4.5

278.8

806

1143

WW502

NOMESCO Finland

Autotransfusion

15.9

278.4

323

130

D64.9

ICD-10 Finland

Anaemia, unspecified

2.0

278.4

3640

12106

PD5BD

NOMESCO Finland

Extensive CT of aorta

5.3

277.9

682

831

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.0

276.8

3537

11664

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

2.1

273.3

3042

9517

T89

ICPC

Diabetes insulin dependent

3.1

273.2

1338

2791

GD1LA

NOMESCO Finland

7.1

271.7

508

458

5253

FHL

Cardiac lung machine

24.7

270.2

268

I21.29

ICD-10 Finland

Acute transmural myocardial infarction with other localization unspecified coronary artery status

1963.9

269.6

314

C08CA05

ATC

nifedipine; systemic

2.5

269.5

2043

5407

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

2.3

267.4

2507

7306

K02

ICPC

Pressure/tightness of heart

4.1

261.9

870

1384

R42

ICD-10 Finland

Dizziness and giddiness

1.6

261.1

7352

30831

AB2

AVR bio, stent

127.9

259.2

201

I48.2

ICD-10 Finland

Chronic atrial fibrillation

2.9

256.4

1412

3157

C02AC05

ATC

moxonidine; oral

2.6

256.3

1756

4418

H25.1

ICD-10 Finland

Senile nuclear cataract

1.6

254.4

9104

40434

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.6

254.3

1669

4107

H02AB06

ATC

prednisolone; systemic

1.5

254.2

15330

76174

N18.8

ICD-10 Finland

Other chronic renal failure

3.7

253.8

949

1651

PE1AT

NOMESCO Finland

Femoral artery PTA

6.1

253.0

541

571

4140B

ICD-9 Finland

Other forms of chronic ischaemic heart disease, Coronary atherosclerosis[ATHEROSCLEROSIS ARTER CORON CORDIS,AHTAUTUNUT]

+∞

253.0

292

R53

ICD-10 Finland

Malaise and fatigue

1.6

252.3

6950

28946

Z49.1

ICD-10 Finland

Extracorporeal dialysis

5.5

252.0

591

688

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

4.3

249.8

765

1139

C09CA01

ATC

losartan; oral

1.6

248.0

8913

39582

Z3231

NOMESCO Finland

Registered nurse

1.6

247.6

8567

37706

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

3.9

247.4

857

1408

SPAT1263

SPAT

Sampling

1.5

246.1

12631

60603

A02BC01

ATC

omeprazole; systemic

1.6

245.4

8714

38572

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

8.0

243.6

417

335

Multi-vessel balloon catheter extension

+∞

243.4

281

M10.9

ICD-10 Finland

Gout, unspecified

2.2

241.8

2389

7108

SPAT1249

SPAT

Treatment-related counselling outside office

1.5

240.9

11717

55525

Z95.3

ICD-10 Finland

Presence of xenogenic heart valve

50.2

240.4

205

AA2

Off pump CABG sternotomy

+∞

240.0

277

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

8.3

238.4

397

307

C03AA03

ATC

hydrochlorothiazide; oral

2.0

237.6

3198

10715

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.7

237.5

1472

3512

N02BE01

ATC

paracetamol; systemic, rectal

1.7

236.6

29852

171763

TFN04, ,

NOMESCO Finland

51.1

236.4

201

SPAT1301

SPAT

No procedures

1.5

234.0

9677

44238

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.8

233.1

1401

3287

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

4.8

232.5

632

848

A10BH05

ATC

linagliptin; oral

2.5

232.5

1784

4741

ZXD10

NOMESCO Finland

Scheduled procedure

1.5

230.8

12038

57739

C07AB03

ATC

atenolol; systemic

2.4

230.1

1935

5365

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

3.0

229.5

1191

2570

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.8

229.0

4436

16718

4019X

ICD-9 Finland

Essential hypertension, Unspecified

3.5

227.3

903

1640

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

2.9

227.1

1288

2926

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

226.9

7022

29999

XF600

NOMESCO Finland

Bloodpressure measurement

2.3

225.5

2037

5829

I49.3

ICD-10 Finland

Ventricular premature depolarization

2.2

224.7

2251

6730

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

5.1

223.7

572

725

FM1DG

NOMESCO Finland

Very extensive MRI examination of heart with high intesity magnet

7.1

223.5

417

375

J45.9

ICD-10 Finland

Asthma, unspecified

1.7

222.9

5625

22812

A02BC03

ATC

lansoprazole; oral

1.5

221.3

9299

42552

PH1AC

NOMESCO Finland

Flebography of over extremity with X-ray

6.7

220.2

431

411

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

2.6

219.6

1518

3831

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

5.2

219.6

542

664

UJF32

NOMESCO Finland

Coloscopy

1.5

217.1

8613

38894

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

3.9

216.9

748

1224

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.8

216.8

4212

15868

G47.3

ICD-10 Finland

Sleep apnoea

1.6

215.7

7542

33102

C07AA07

ATC

sotalol; systemic

2.9

215.5

1177

2616

2500A

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]

4.2

215.4

683

1046

A10AD01

ATC

insulin (human); parenteral

4.8

215.2

580

772

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.3

215.1

1975

5689

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.7

215.0

5076

20203

PEN23

NOMESCO Finland

Plastic repair of femoral artery

6.9

214.5

411

382

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

6.9

214.4

410

380

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

4.6

214.0

610

854

FN2EA

NOMESCO Finland

Coronary rotablation

+∞

213.9

247

A11CC03

ATC

alfacalcidol; systemic

3.5

213.5

856

1564

NHQ40

NOMESCO Finland

Amputation of toe

4.2

213.3

667

1010

4111X

ICD-9 Finland

Other acute and subacute forms of ischaemic heart disease, Intermediate coronary syndrome[PITKITTYNYT ANGINA PECTORIS -KOHTAUS,MÄÄRITTELEMÄT]

+∞

213.1

246

I20.10

ICD-10 Finland

Angina angiospastic

799.2

213.0

251

XF640, ,

NOMESCO Finland

3.3

211.8

935

1823

PD3YT

NOMESCO Finland

Pelvic artery PTA with stent

5.3

211.7

518

629

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.1

211.7

2429

7659

R00.1

ICD-10 Finland

Bradycardia, unspecified

3.0

211.1

1092

2351

1CX08, ,

NOMESCO Finland

42.0

210.7

185

K83

ICPC

Heart valve disease NOS

9.4

210.4

321

218

FP1C5

NOMESCO Finland

Resting ECG, 15 leads

6.1

209.6

446

468

XCK10

NOMESCO Finland

Photography of fundus of eye

1.9

207.6

3258

11476

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.4

207.5

1728

4765

WX870

NOMESCO Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

16570

81195

1.55

318.77

3.0

2.5

—

(3024354) Oxygen [Partial pressure] in Venous blood

3781

12179

2.08

317.51

4.1

2.7

4.67

4.59

kpa

1.41

3644

11798

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

12155

55521

1.59

316.47

3.1

2.5

58.40

65.56

u/l

2.42

11312

50766

(3023520) Reticulocytes [#/volume] in Blood

4214

14162

2.00

315.63

2.6

72.34

68.25

e9/l

9.36

3249

10619

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

7357

27025

1.91

307.65

2.0

1.8

—

(3020891) Body temperature

2419

5833

2.74

307.65

5.9

4.4

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

10797

30496

2.80

307.65

5.9

2.6

1153.39

63.77

ng/l

28.50

9619

23344

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

5526

11557

3.41

307.65

3.6

2.1

258.70

140.73

ng/l

44.10

5138

10308

(3012095) Magnesium [Moles/volume] in Serum or Plasma

7624

27838

1.94

307.65

3.9

3.2

0.81

mmol/l

0.28

7172

25896

(3043409) Potassium [Moles/volume] in Arterial blood

1950

4182

3.06

307.65

5.2

4.2

3.93

3.83

mmol/l

13.06

1934

4155

(3018677) aPTT in Platelet poor plasma by Coagulation assay

8430

23764

2.64

307.65

2.6

1.8

30.71

29.32

52.28

8244

23040

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

5354

18208

2.02

307.65

1.9

1.7

—

(3027945) Reticulocytes/100 erythrocytes in Blood

5462

18772

2.00

307.65

2.5

1.88

1.75

15.63

4874

16433

(3001122) Ferritin [Mass/volume] in Serum or Plasma

14305

64449

1.68

307.65

3.6

2.6

154.45

159.51

ug/l

0.86

13178

58626

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

18315

62530

2.80

307.65

5.4

2.7

148.79

27.47

ng/l

4.83

14209

43457

(3014111) Lactate [Moles/volume] in Serum or Plasma

4564

14781

2.10

307.65

9.1

6.2

1.39

1.35

mmol/l

1.74

4448

14396

(3012544) pH of Venous blood

4966

15293

2.23

307.65

5.2

3.3

7.37

7.39

1.22

(3022948) Iron [Moles/volume] in Serum or Plasma

7756

24514

2.29

307.65

3.4

2.2

11.87

14.13

umol/l

2.13

7278

22628

(3008152) Bicarbonate [Moles/volume] in Arterial blood

3891

9056

2.93

307.65

8.6

6.5

24.52

24.77

mmol/l

3.49

3734

8616

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

3202

8675

2.47

307.65

12.0

8.5

—

(3012516) Albumin [Mass/volume] in Urine

13754

54540

1.98

307.65

3.6

3.2

308.00

432.92

mg/l

2.88

9387

33562

(3002032) Base excess in Venous blood by calculation

4674

14899

2.14

307.65

5.2

3.4

1.77

1.97

mmol/l

2.86

4027

12755

(3018405) Lactate [Moles/volume] in Arterial blood

2210

4927

2.96

307.65

4.9

3.9

1.37

1.38

mmol/l

0.16

2169

4845

(3022217) INR in Platelet poor plasma by Coagulation assay

21410

80838

2.75

307.65

20.7

11.5

1.36

1.21

inr

74.22

6256

22143

(3004789) Transferrin [Mass/volume] in Serum or Plasma

7308

22609

2.32

307.65

3.4

2.2

2.31

2.30

g/l

1.59

6825

20682

(3024561) Albumin [Mass/volume] in Serum or Plasma

16568

78421

1.64

307.65

5.9

4.7

34.74

35.35

g/l

33.13

15473

72425

(3023368) Bacteria identified in Blood by Culture

11839

47775

1.86

307.65

5.0

4.1

—

(3014007) Fractional oxyhemoglobin in Arterial blood

3722

9895

2.54

307.65

11.0

8.5

93.81

93.97

0.80

3708

9865

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

3697

9831

2.54

307.65

10.8

8.4

1.39

1.36

1.06

3677

9766

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

18778

90600

1.67

307.65

9.7

6.1

1.20

1.22

mmol/l

176.68

16043

76321

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

6588

17979

2.62

307.65

8.8

6.7

5.04

5.14

kpa

13.67

6309

17186

(3016502) Oxygen saturation in Arterial blood

6100

15742

2.76

307.65

9.1

7.1

95.58

95.73

0.91

5889

15201

(3003458) Phosphate [Moles/volume] in Serum or Plasma

6208

22232

1.93

307.65

8.8

5.0

1.08

1.01

mmol/l

56.70

5860

20578

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

6667

10548

4.71

307.65

2.9

1.8

10.26

3.86

ug/l

57.92

6032

8675

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

10719

39648

2.03

307.65

2.6

2.1

3.10

2.94

mg/l

7.18

9367

33141

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

17464

82453

1.68

307.65

8.7

5.5

1.20

1.22

mmol/l

160.76

16197

74335

(3000991) Gas panel - Venous blood

4419

13767

2.18

307.65

10.9

7.4

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

19748

92916

1.79

307.65

6.3

6.5

11.98

11.52

umol/l

5.39

18859

88002

(3044889) 12 lead EKG panel

25091

127186

1.88

307.65

5.8

3.2

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

16949

43279

3.87

307.65

3.8

2.2

1806.44

1005.64

ng/l

59.13

15276

35577

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

9139

34357

1.92

307.65

2.2

1.6

1.24

1.33

mg/l

1.25

7085

26597

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

3714

9805

2.56

307.65

11.0

8.5

0.67

0.66

0.75

3693

9750

(3002173) Hemoglobin [Mass/volume] in Arterial blood

5633

14613

2.72

307.65

9.7

7.4

120.11

121.97

g/l

7.71

5501

14232

(3020682) Albumin/Creatinine [Ratio] in Urine

14345

57589

1.98

307.65

4.3

3.7

13.69

7.37

mg/mmol

26.56

9460

35330

(3003396) Base excess in Arterial blood by calculation

6585

18007

2.62

307.65

8.8

6.6

1.04

1.06

mmol/l

0.18

5289

14583

(3027801) Oxygen [Partial pressure] in Arterial blood

6585

17969

2.62

307.65

8.8

6.7

11.82

12.63

kpa

25.97

6303

17172

(3021447) Carbon dioxide [Partial pressure] in Venous blood

4678

14908

2.14

307.65

5.1

3.4

5.84

5.81

kpa

1.45

4534

14505

(3019060) Gas panel - Arterial blood

4133

9662

2.93

307.65

5.7

4.5

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

5368

18138

2.03

307.65

1.9

1.7

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

2283

4968

3.04

307.65

3.7

2.5

0.33

0.36

u/ml

3.80

1437

2597

(3020779) Urea [Moles/volume] in Serum or Plasma

5137

13880

2.57

307.65

11.1

5.9

11.09

9.51

mmol/l

36.83

4926

13149

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

7006

21177

2.37

307.65

3.5

2.3

20.65

23.49

51.60

5943

17951

(3013826) Glucose [Moles/volume] in Serum or Plasma

23128

102775

2.26

307.65

6.9

4.2

7.15

6.74

mmol/l

118.84

22162

96227

(3009508) Creatinine [Moles/volume] in Urine

13871

56430

1.92

307.65

3.6

3.1

7.18

7.67

mmol/l

31.77

11735

46912

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

14322

52258

2.24

307.65

2.6

2.0

219.05

213.42

u/l

0.24

13427

48791

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

25853

140935

1.62

304.23

8.8

7.6

80.83

79.31

u/l

4.87

24597

132018

(3004119) Hemoglobin [Mass/volume] in Venous blood

3132

9568

2.18

299.87

4.6

2.8

123.82

130.76

g/l

45.05

3055

9386

(3018418) pH of Serum or Plasma

11662

53577

1.57

289.55

5.4

4.0

7.40

0.44

2428

9697

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

3163

9889

2.13

285.19

9.5

5.9

24.58

24.92

mmol/l

5.55

3139

9795

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

5287

19926

1.80

277.44

4.2

4.5

250.79

240.39

u/l

4.17

4983

18772

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

2298

6434

2.35

268.56

6.3

4.5

1.78

1.65

4.16

2160

6058

(3026008) Bacteria identified in Urine by Culture

11425

52979

1.54

266.64

3.6

3.1

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

2494

7280

2.26

264.96

1.7

1.62

1.59

g/l

0.45

2142

6187

(3026493) Urate [Moles/volume] in Serum or Plasma

10525

48022

1.55

263.31

3.2

2.5

3715.25

4850.01

umol/l

2.16

9136

41717

(3007930) Methemoglobin/Hemoglobin.total in Blood

2248

6313

2.34

260.73

6.4

4.5

0.91

0.89

1.85

2111

5942

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

307

132

14.83

257.18

8.3

9.0

—

(3047181) Lactate [Moles/volume] in Blood

1864

4825

2.53

257.04

7.2

5.2

1.38

1.30

mmol/l

2.39

1683

4250

(3031040) Bacteria [#/volume] in Urine by Automated count

21737

115819

1.50

255.52

5.5

4.3

1172.21

1473.46

e6/l

0.33

326

1659

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

2856

8963

2.11

253.72

11.7

8.3

24.13

24.38

mmol/l

3.43

2743

8694

(4094501) Cardiovascular stress test using bicycle ergometer

1741

4400

2.58

251.78

1.2

1.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

1205

2511

3.11

246.15

3.0

3.1

0.85

0.78

nmol/l

4.32

912

1906

(3004451) EKG impression Narrative

482

466

6.62

243.39

1.4

1.2

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

277

114

15.48

236.52

8.1

9.4

—

(3006315) Basophils [#/volume] in Blood

16994

87038

1.46

234.39

6.3

5.9

0.04

e9/l

7.99

14756

74180

(3001604) Monocytes [#/volume] in Blood

16954

86806

1.46

234.11

6.3

5.9

0.64

0.59

e9/l

76.85

14713

74025

(3013115) Eosinophils [#/volume] in Blood

17454

89898

1.46

233.37

6.5

6.1

0.21

0.19

e9/l

18.25

15414

77574

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

15103

75720

1.46

231.67

2.2

2.0

94.14

95.91

pmol/l

4.16

8065

38394

(3000850) Epithelial cells [#/volume] in Urine

8332

36904

1.56

231.64

3.2

2.5

5.06

5.15

e6/l

0.26

7517

32943

(3018572) Chloride [Moles/volume] in Blood

1399

3315

2.74

228.52

8.1

6.2

105.05

104.89

mmol/l

0.56

1283

2990

(3039000) Anion gap in Blood

1399

3315

2.74

228.52

8.1

6.2

11.44

11.15

mmol/l

2.17

1282

2990

(3019198) Lymphocytes [#/volume] in Blood

17298

89153

1.45

228.47

6.4

5.9

1.88

1.93

e9/l

2.32

15344

77693

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

11702

55930

1.49

227.37

3.4

3.3

39.45

34.48

u/l

2.80

11065

52782

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

29466

169373

1.65

226.84

8.3

5.6

43.24

39.66

mmol/mol

307.65

27699

154494

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

2042

5852

2.28

225.30

3.0

2.0

588.34

525.27

ug/l

0.26

1960

5467

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

2460

7616

2.12

225.23

5.6

3.7

23.92

24.28

mmol/l

5.74

2391

7443

(3019309) Folate [Moles/volume] in Red Blood Cells

7666

33507

1.57

224.60

1.9

1.7

1216.13

1137.80

nmol/l

9.93

5922

24610

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

2403

7440

2.12

219.80

3.6

2.5

1.29

1.26

0.60

2395

7402

(3013650) Neutrophils [#/volume] in Blood by Automated count

19222

101591

1.44

216.99

8.7

9.7

4.49

4.07

e9/l

92.46

16871

87814

(3021960) Folate [Moles/volume] in Serum or Plasma

9047

41466

1.51

211.84

1.7

1.5

19.46

20.82

nmol/l

13.24

7880

34693

(3030467) Casts [#/volume] in Urine by Automated count

10552

49932

1.48

211.67

3.8

3.1

0.55

0.42

e6/l

3.21

8344

37363

(40760892) CBC W Ordered Manual Differential panel - Blood

15994

82021

1.43

209.78

7.1

6.4

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

2428

7697

2.07

208.57

4.5

2.9

25.15

25.34

mmol/l

1.73

2353

7486

(3007853) Bacteria identified in Skin by Aerobe culture

5000

20012

1.68

206.68

2.1

1.7

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

2329

7319

2.09

204.55

3.6

2.5

0.65

0.50

2322

7293

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

220

18.67

202.40

7.5

5.0

—

(3002582) Erythrocytes [#/volume] in Urine

11307

54609

1.46

202.20

3.9

3.1

78.99

81.83

e6/l

0.07

8983

41268

(3042936) Bacteria identified in Isolate by Culture

5934

24984

1.61

200.41

2.5

1.9

—

(36304419) Bacteria [Presence] in Urine

10188

48280

1.47

200.35

3.7

3.0

—

(3029937) Albumin [Presence] in Urine by Test strip

9579

44843

1.48

200.22

5.2

3.9

0.00

estimate

0.07

3088

14470

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1496

3933

2.47

198.85

3.6

2.7

24.62

24.86

mmol/l

1.28

1470

3837

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

2162

6700

2.11

196.61

2.1

1.9

1.91

2.40

ug/l

1.24

1950

5866

(3013512) EKG study

11210

54323

1.45

195.23

5.6

3.4

—

(3018095) Leukocytes [#/volume] in Urine

12705

63045

1.43

194.66

4.4

3.6

99.16

97.46

e6/l

0.07

9555

44244

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

2743

9318

1.94

194.12

1.6

1.4

—

(3028626) Oxygen [Partial pressure] in Capillary blood

1309

3266

2.59

193.35

3.3

2.6

7.98

8.10

kpa

1.72

1290

3187

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

3058

10816

1.86

191.62

4.3

3.3

5.11

5.17

kpa

3.01

2920

10156

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

3661

13722

1.77

190.04

3.1

2.6

57.42

66.58

ml/min/173m2

36.25

1692

5113

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

4466

17751

1.68

187.92

4.2

3.2

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

2232

7126

2.05

187.52

4.9

3.4

49.37

48.04

1.57

2208

7050

(3009343) pH of Capillary blood

3013

10682

1.86

187.22

4.3

3.3

7.41

7.42

2.44

496

1273

(3035350) Ketones [Presence] in Urine by Test strip

16353

85319

1.40

185.58

4.6

3.5

0.00

estimate

0.05

3475

16083

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

1476

4042

2.37

179.52

2.6

2.1

152.28

93.19

ug/min

3.97

928

2342

(3024928) Oxygen saturation in Venous blood

1265

3224

2.54

178.94

4.5

2.5

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

2902

10313

1.85

178.59

4.2

3.2

1.82

1.74

mmol/l

0.47

2106

7796

(40767503) Oxygen content in Capillary blood by calculation

1282

3298

2.51

177.93

3.0

2.3

15.90

16.51

4.99

705

1714

(3006576) Bicarbonate [Moles/volume] in Blood

341

318

6.84

177.46

7.7

4.3

25.51

24.89

mmol/l

1.23

311

299

(3037467) Urinalysis macro (dipstick) panel - Urine

22194

122527

1.40

175.92

5.3

4.2

—

(3021901) Oxygen saturation in Capillary blood

1141

2789

2.64

175.21

3.3

2.6

—

(3033658) Prothrombin time (PT) actual/Normal

9712

46533

1.44

175.16

5.0

3.8

85.04

91.39

102.83

9465

45440

(3009261) Glucose [Presence] in Urine by Test strip

16455

86525

1.38

173.61

4.6

3.5

0.00

estimate

0.33

3095

14758

(3021601) Nitrite [Presence] in Urine by Test strip

16273

85533

1.38

171.14

5.8

4.7

0.00

estimate

0.19

3293

15066

(3010421) pH of Blood

1460

4098

2.31

167.91

5.1

3.4

7.42

1.15

1333

3744

(3044640) Blood type and Crossmatch panel - Blood

11364

56363

1.41

167.52

2.9

2.4

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

3304

12461

1.75

166.61

1.7

1.6

—

(3027315) Oxygen [Partial pressure] in Blood

1318

3555

2.40

165.49

5.0

3.5

8.48

8.63

kpa

1.99

1293

3463

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

8004

37466

1.46

160.52

1.8

1.7

44695904.96

30521284.84

pmol/l

1.02

6551

30412

(3013290) Carbon dioxide [Partial pressure] in Blood

1302

3551

2.37

159.51

5.0

3.5

4.99

5.01

kpa

0.48

1277

3460

(3012501) Base excess in Blood by calculation

1301

3551

2.37

159.12

5.0

3.5

2.44

2.64

mmol/l

1.52

893

2459

(1616796) Gas panel - Central venous blood

1283

3481

2.38

158.98

4.7

3.3

—

(3042733) HLA Ab [Presence] in Serum

328

343

6.10

154.69

5.3

5.1

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

9926

48607

1.41

154.35

1.9

1.6

1.43

1.37

mmol/l

6.09

8238

40323

(3019150) Specific gravity of Urine by Refractometry

7740

36228

1.45

154.24

5.0

3.9

1.02

kg/l

0.51

1157

5538

(3006504) Eosinophils/100 leukocytes in Blood

15578

82292

1.36

151.44

6.7

6.1

2.92

2.88

1.15

14651

76422

(3019069) Monocytes/100 leukocytes in Blood

15653

82780

1.36

150.87

7.0

6.4

8.93

8.73

11.98

14734

76997

(3022096) Basophils/100 leukocytes in Blood

15157

79761

1.36

150.81

6.7

6.1

0.67

0.69

4.21

14237

73892

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

30222

178297

1.54

149.73

22.5

13.4

25.28

25.29

mg/l

0.02

25976

139744

(3011397) Hemoglobin [Presence] in Urine by Test strip

8481

40601

1.42

148.71

4.4

3.5

—

(40761535) Cells panel - Urine sediment

3565

14160

1.66

147.86

4.1

3.3

—

(3026782) Osmolality of Urine

7573

35576

1.44

146.83

3.5

2.8

521.75

552.00

mosm/kgh2o

26.25

6527

30384

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1435

4245

2.19

145.59

3.1

2.3

3.67

3.71

g/l

0.41

1390

4043

(3015736) pH of Urine

13248

68544

1.36

145.05

4.2

3.2

5.73

5.78

0.62

548

4760

(3028271) Lactate [Moles/volume] in Capillary blood

967

2398

2.59

144.17

2.1

1.7

1.72

1.77

mmol/l

0.81

948

2335

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

8885

43119

1.41

143.23

2.8

2.3

—

(3013707) Erythrocyte sedimentation rate by Westergren method

23466

132658

1.36

142.05

4.9

3.9

14.95

12.52

mm/h

86.06

21764

121589

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

3360

13286

1.66

141.38

5.4

3.5

120.86

82.96

ng/l

51.63

2922

11286

(3020630) Protein [Mass/volume] in Serum or Plasma

3696

15005

1.62

140.23

2.4

2.7

65.79

66.63

g/l

8.59

3421

13502

(3026250) Tacrolimus [Mass/volume] in Blood

386

528

4.66

138.99

38.4

31.4

7.36

6.99

ug/l

2.13

352

470

(3002030) Lymphocytes/100 leukocytes in Blood

15865

84818

1.34

137.17

6.8

6.2

25.71

27.71

89.83

14950

79094

(3018010) Neutrophils/100 leukocytes in Blood

15623

83517

1.33

133.91

6.6

5.9

58.91

57.18

57.29

14706

77823

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

12513

64777

1.35

132.92

4.9

3.7

—

(3021589) Normoblasts [#/volume] in Blood

14602

77416

1.33

131.65

12.7

9.3

0.00

e9/l

0.14

12141

62909

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

23175

131795

1.33

124.62

4.3

3.8

15.05

14.88

pmol/l

18.43

21104

118023

(3006184) Hemoglobin [Mass/volume] in Capillary blood

1242

3730

2.15

121.12

2.6

2.0

127.25

130.51

g/l

3.73

952

2579

(3022806) Fractional oxyhemoglobin in Capillary blood

780

1895

2.64

120.93

1.9

1.8

89.17

89.53

0.78

768

1868

(4200892) Spirometry reversibility

3129

12648

1.62

119.69

1.5

1.4

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

3489

14487

1.58

119.43

2.1

2.4

365.52

375.83

nmol/l

1.99

3194

13306

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

4576

20258

1.49

116.89

2.7

2.8

8.38

9.61

umol/l

3.33

4011

17769

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

3933

16873

1.53

116.43

1.5

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

29030

171720

1.41

114.49

5.6

3.9

1.40

1.32

mmol/l

48.83

26989

154294

(40768797) Stomach Pathology biopsy report

5330

24573

1.44

109.98

1.3

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1450

4815

1.94

107.88

1.3

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

6554

31488

1.39

106.70

3.1

2.7

1.14

1.23

e6/l

0.37

3945

17572

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2625

10440

1.64

106.52

1.7

—

(40758558) Short blood count panel - Blood

8896

44986

1.34

104.15

6.6

7.4

—

(21494755) Public health laboratory ask at order entry panel

1269

14720

0.53

103.95

1.4

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

27607

162643

1.35

102.78

5.3

4.5

2.10

2.13

mu/l

0.14

25367

146582

(3004588) Protein electrophoresis panel - Serum or Plasma

3022

12582

1.57

101.31

2.2

2.5

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1184

3764

2.02

99.40

1.6

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

803

2199

2.34

97.16

7.5

5.7

11.88

11.49

mg/l

1.59

728

2023

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1143

3623

2.03

96.70

1.6

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

4956

23044

1.42

96.27

10.6

6.0

—

(3036489) Thrombin time

1619

5801

1.80

95.17

2.7

1.7

22.34

21.19

5.81

1464

5056

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

3313

14393

1.50

91.02

5.2

3.6

1.22

1.23

mmol/l

16.36

2918

12424

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1927

7400

1.68

88.86

1.4

1.6

13.21

16.24

u/ml

0.25

213

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

738

2026

2.33

88.80

1.6

1.5

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1238

4184

1.90

87.24

3.4

2.2

211.86

194.35

8.55

1183

3925

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

578

1437

2.57

85.67

1.3

1.54

1.36

nmol/l

3.06

518

1295

(3022313) Gas panel - Capillary blood

2022

8014

1.63

82.46

4.5

3.3

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1324

4658

1.83

82.39

3.0

1.9

88.58

92.55

7.76

1285

4427

(40760888) Immunoglobulin light chains.free panel - Serum

1212

4176

1.87

80.50

2.8

3.7

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1535

5698

1.74

79.82

2.9

3.6

44.52

43.53

mg/l

0.07

1204

4682

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1497

5528

1.74

79.27

2.9

3.6

7.48

3.07

ratio

0.41

102

395

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1630

6170

1.70

79.05

2.8

2.6

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

1531

5707

1.73

78.43

3.0

3.6

95.41

65.00

mg/l

0.36

1201

4687

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

883

2759

2.05

77.55

1.6

1.4

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1400

5115

1.76

76.86

1.9

1.6

—

(3024932) HLA-DR beta [Type]

252

401

4.00

75.92

1.0

1.2

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1247

4438

1.81

74.70

3.9

2.7

1.92

1.48

mg/l

43.34

1143

4044

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1143

3968

1.85

74.11

1.5

1.6

—

(3040151) Glucose [Moles/volume] in Capillary blood

618

1714

2.30

72.70

7.5

9.6

7.66

7.48

mmol/l

0.51

518

1406

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

777

2372

2.10

72.51

1.5

1.4

—

(3000492) Spirometry study

3535

16224

1.42

72.15

1.5

—

(3024471) HLA-A [Type]

252

418

3.83

71.95

1.0

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

708

2099

2.16

71.14

1.5

1.4

—

(3000012) Reticulocyte production index

763

2334

2.09

70.83

1.9

2.3

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

31204

189604

1.39

70.46

28.6

14.8

139.47

139.74

mmol/l

58.66

30784

184283

(3023183) Ammonium ion [Moles/volume] in Plasma

1077

3732

1.85

70.21

2.6

2.8

31.60

34.97

umol/l

4.84

971

3338

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

5919

29642

1.32

69.45

3.3

2.9

2.37

2.49

e6/l

0.39

3354

15795

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

892

2923

1.95

68.70

1.8

1.4

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

11485

62498

1.24

68.54

3.4

3.6

2.35

2.36

mmol/l

10.30

10101

54177

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

861

2791

1.98

68.38

1.6

1.7

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1485

5718

1.67

67.44

1.6

264.76

262.05

titre

0.01

239

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

799

2535

2.02

67.34

1.3

1.5

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

984

3361

1.88

67.05

7.9

4.4

1932.21

2673.20

iu/ml

0.18

188

453

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

809

2587

2.00

66.73

1.8

1.4

120.75

111.36

u/ml

1.26

208

561

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

572

1593

2.29

66.68

1.6

1.4

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

572

1594

2.29

66.58

1.6

1.4

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

3715

17448

1.39

65.99

2.2

2.3

0.21

g/l

5.08

3408

16209

(3028026) IgM [Mass/volume] in Serum or Plasma

2261

9671

1.51

65.94

1.9

1.25

1.39

g/l

1.90

2073

8701

(3037522) Nuclear Ab [Titer] in Serum

4555

22122

1.35

65.56

1.4

1.3

560.67

544.82

titre

0.20

1019

4581

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

3590

16805

1.39

64.98

2.8

2.5

38.66

47.58

u/l

1.36

3044

14374

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

877

2916

1.93

64.76

1.7

1.4

15.93

17.10

u/ml

0.11

(3002179) Metamyelocytes/100 leukocytes in Blood

2943

13333

1.43

64.09

3.9

4.0

0.71

0.01

1014

4641

(3017181) Myelocytes/100 leukocytes in Blood

3201

14731

1.41

63.89

4.0

4.1

0.96

1.01

0.54

1173

5392

(3005719) IgG [Mass/volume] in Serum or Plasma

2788

12512

1.44

63.87

2.7

2.8

10.48

10.63

g/l

1.00

2584

11342

(3010375) cycloSPORINE [Mass/volume] in Blood

297

604

3.13

63.09

27.1

26.6

109.87

110.39

ug/l

0.04

227

530

(3003434) Protein [Mass/volume] in Pleural fluid

719

2248

2.04

63.05

1.5

1.4

29.54

35.33

g/l

24.06

636

2058

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

588

1699

2.21

62.92

1.7

1.5

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

31219

190194

1.37

62.81

28.8

14.9

4.03

3.97

mmol/l

255.30

30770

184550

(40761536) Microorganisms panel - Urine sediment

3090

14190

1.41

62.34

5.3

3.8

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

29500

178307

1.30

62.08

6.3

4.3

1.31

1.48

mmol/l

307.65

27609

161742

(3017817) Protein [Mass] in Urine collected for unspecified duration

525

1456

2.30

61.81

2.1

2.5

0.10

0.53

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

3361

15699

1.39

61.41

1.9

1.5

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

679

2099

2.07

61.36

2.0

2.3

32.35

32.84

2.00

672

2084

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

768

2486

1.98

61.24

1.4

1.2

301.51

277.54

u/ml

1.12

518

1527

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

773

2527

1.96

59.95

3.1

2.3

3428.18

6877.81

u/ml

0.38

159

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1536

14807

0.64

59.41

2.2

1.8

—

(3020876) Protein [Mass/time] in 24 hour Urine

612

1846

2.12

58.93

2.6

2.4

1.44

1.22

g/24h

1.04

334

880

(3025159) Blasts/100 leukocytes in Blood

2871

13145

1.42

58.73

4.1

4.2

0.17

0.36

1.88

849

3877

(3016750) Collection duration of Urine

378

921

2.61

58.42

2.6

1.9

497.90

496.82

min

0.07

289

662

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

29419

178044

1.29

58.15

6.1

4.6

6.38

5.97

mmol/l

307.65

27063

160654

(3022493) Free Hemoglobin [Mass/volume] in Plasma

277

568

3.10

58.10

12.8

1.4

2210.09

2752.40

mg/l

0.14

209

380

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

2155

9375

1.48

57.68

3.1

3.3

4.31

4.47

pmol/l

10.41

1911

8226

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

6623

34406

1.27

57.10

2.9

3.3

2.46

mmol/l

1.83

5713

30196

(3021440) Promyelocytes/100 leukocytes in Blood

3014

13995

1.40

56.78

4.0

4.1

0.10

0.12

1.15

988

4686

(40757494) Bilirubin.total [Moles/volume] in Blood

332

770

2.74

56.34

2.0

2.3

28.39

28.98

umol/l

0.01

(3004775) Volume in Urine collected for unspecified duration

474

1324

2.28

54.95

2.7

2.0

736.62

673.85

2.19

345

867

(3023419) Bacteria identified in Sputum by Culture

763

2559

1.91

54.94

2.2

2.4

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

921

3284

1.79

54.76

1.2

86.67

112.44

titre

0.37

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

1222

4720

1.66

54.73

1.7

1.5

1.18

g/l

0.02

1163

4485

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

3444

16448

1.36

54.50

1.9

1.4

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

1187

4561

1.67

54.22

1.7

1.5

0.24

g/l

1.18

1130

4313

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

682

2214

1.97

53.97

1.6

1.4

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

792

2706

1.87

53.92

1.4

1.2

—

(3019977) pH of Arterial blood

345

837

2.62

53.80

2.6

2.4

7.43

7.42

0.74

128

311

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

29646

179928

1.28

53.76

6.4

4.3

3.98

4.81

mmol/l

307.65

27942

164211

(3052851) Hemolysis interference index of Serum or Plasma

1347

5361

1.61

53.62

3.9

3.0

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

848

2974

1.82

53.20

5.4

2.6

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1121

4267

1.68

53.04

1.8

2.0

11.88

11.27

mg/l

0.64

1038

3949

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

972

3559

1.75

52.85

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

972

3561

1.75

52.74

1.4

1.3

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

760

2585

1.88

52.47

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

760

2585

1.88

52.47

1.6

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

13045

73282

1.20

52.41

2.5

2.2

76.37

1343.95

nmol/l

0.50

11558

64823

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

12808

71845

1.20

52.22

4.6

4.9

2.39

3.31

ug/l

6.37

11477

64986

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

439

1217

2.30

51.81

1.5

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

6490

34038

1.25

50.73

1.3

1.2

1.70

1.80

u/ml

0.22

1708

8488

(3045716) Anion gap in Serum or Plasma

278

643

2.75

47.50

3.1

2.3

9.83

9.75

mmol/l

0.13

270

628

(3023199) Leukocytes [#/volume] in Pleural fluid

622

2051

1.93

47.11

1.5

2189.00

3864.48

e6/l

1.26

453

1489

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1019

3914

1.67

46.60

1.6

1.4

—

(3007164) IgA [Mass/volume] in Serum or Plasma

5760

30065

1.25

46.40

1.5

2.73

2.57

g/l

5.26

3429

17369

(3025941) Bacteria identified in Stool by Culture

1978

8840

1.44

45.83

1.3

1.2

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

1618

6977

1.49

45.00

1.8

1.9

37.76

39.92

u/l

3.43

1336

6223

(3034770) Mitochondria Ab [Titer] in Serum

1134

4519

1.61

44.86

1.2

832.59

925.86

titre

0.23

145

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1644

7132

1.48

44.38

4.8

3.5

24.69

24.97

mmol/l

3.18

1515

6550

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

10.14

44.32

2.2

2.3

2.27

2.85

mg/l

0.70

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

943

9512

0.62

44.25

1.7

1.5

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

439

1306

2.14

43.88

2.2

2.4

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

913

3461

1.69

43.86

1.6

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

945

3616

1.67

43.84

1.3

1.2

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

430

1270

2.16

43.76

1.1

1.2

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

30135

184069

1.26

43.65

7.3

4.8

2.17

2.87

mmol/l

307.65

28328

167087

(3011648) Oxygen content in Venous blood

423

1246

2.16

43.34

2.3

2.0

10.48

11.32

3.44

423

1246

(3036782) Glucose [Moles/volume] in Pleural fluid

491

1539

2.03

42.89

1.4

1.3

7.12

5.98

mmol/l

13.58

453

1414

(3017569) Oxygen content in Arterial blood

275

669

2.61

42.78

2.0

2.2

—

(3003181) Sodium [Moles/volume] in Urine

834

3133

1.70

41.43

1.4

1.3

58.70

62.52

mmol/l

1.98

669

2449

(3007566) Smooth muscle Ab [Titer] in Serum

1131

4592

1.58

41.39

1.2

110.09

142.21

titre

0.65

107

384

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

309

819

2.40

40.39

2.2

2.1

208.53

65.99

ug/min

1.07

170

(3037756) Immunofixation for Serum or Plasma

984

3902

1.61

39.72

1.5

1.7

—

(3011985) Renin [Units/volume] in Plasma

655

2327

1.80

39.48

1.4

96.76

57.54

mu/l

2.36

574

2060

(3044242) Glucose [Moles/volume] in Arterial blood

268

674

2.53

39.09

2.0

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1276

5396

1.51

38.92

1.5

1.4

257.96

264.65

ug/g

0.53

764

3160

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

484

1565

1.97

38.85

1.4

1.3

284.95

605.20

u/l

5.50

460

1483

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

5412

28575

1.23

38.45

1.3

38.86

41.67

iu/ml

0.41

1703

9173

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

132

217

3.86

38.38

3.1

2.3

99.74

52.43

mg/l

—

(21494890) Protein electrophoresis panel - 24 hour Urine

546

1848

1.88

38.36

1.8

2.2

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

758

2834

1.71

38.33

1.2

1.3

30.30

37.66

u/l

1.07

668

2431

(3002385) Erythrocyte distribution width [Ratio]

25425

153233

1.18

37.94

26.3

16.1

15.37

15.21

2.16

25091

150272

(3030905) Polymorphonuclear cells [#/volume] in Blood

848

3277

1.65

37.92

3.4

3.3

4.34

4.07

e9/l

2.67

848

3269

(3012441) Differential panel - Pleural fluid

530

1788

1.89

37.62

1.5

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

122

193

4.01

37.29

6.0

4.4

41.34

51.47

ug/min

0.84

103

153

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

197

437

2.86

36.42

1.1

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1608

7221

1.43

36.16

2.2

2.4

3.74

3.76

g/l

0.25

1476

6425

(3001019) Free T4 and TSH panel - Serum or Plasma

653

6856

0.59

36.11

1.6

1.7

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

541

1866

1.85

35.89

1.5

53459.14

60320.54

e6/l

0.19

330

1110

(3045788) Cell count panel - Pleural fluid

467

1537

1.93

35.68

1.5

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1608

7239

1.42

35.67

2.2

2.4

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

201

457

2.79

35.58

1.1

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1608

7247

1.42

35.45

2.2

2.4

7.67

7.38

g/l

8.06

1477

6442

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

126

213

3.75

35.35

5.3

5.4

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1388

6090

1.46

35.31

1.2

1.26

0.87

u/ml

0.49

138

504

(3014765) Yersinia sp identified in Stool by Organism specific culture

1109

4653

1.52

35.09

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

1110

4660

1.52

35.02

1.2

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

643

2355

1.74

35.01

1.3

0.19

0.26

nmol/l

0.74

173

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

313

897

2.22

34.39

1.2

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1506

6757

1.43

34.01

2.2

2.4

9.96

10.28

g/l

2.02

1359

5917

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1095

4618

1.52

33.83

1.2

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

2045

9673

1.36

33.79

2.5

2.4

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

3720

19100

1.26

33.54

1.9

1.6

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

5049

26826

1.22

33.27

1.3

1.2

12.10

14.61

u/ml

1.46

1804

9673

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

267

725

2.34

33.21

2.0

95.99

100.92

1.11

258

684

(3000494) Fungus identified in Specimen by Culture

4126

21470

1.24

33.05

1.6

1.4

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

635

2370

1.71

32.38

1.3

2.29

1.45

nmol/l

0.20

604

2281

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

595

2183

1.74

32.24

1.3

271.50

297.85

pmol/l

0.79

487

1893

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

2679

21371

0.78

32.00

1.4

—

(40768446) Kidney Pathology biopsy report

233

605

2.45

31.94

1.9

1.5

—

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

15.62

31.80

9.2

7.8

44.27

52.88

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1136

4893

1.48

31.72

1.6

1.5

10.97

16.68

iu/ml

1.29

115

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1505

6847

1.41

31.44

2.2

2.4

3.01

2.93

g/l

2.47

1375

6048

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1617

7457

1.39

31.21

2.0

1.9

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

10116

57395

1.16

31.15

4.2

4.1

22.93

21.45

16.03

4701

27449

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

473

1640

1.84

30.94

3.4

2.7

—

(3042631) Mycobacterium sp identified in Specimen

657

2509

1.67

30.81

2.6

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

561

2058

1.74

30.44

1.3

—

nmol/l

—

(3041096) Erythrocytes [Presence] in Urine by Automated

8078

45112

1.17

30.30

4.3

3.2

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

430

1464

1.87

29.79

1.1

—

(3012565) Volume of 24 hour Urine

273

787

2.20

29.66

2.2

1808.20

2007.23

1.99

241

697

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1493

6857

1.39

29.51

1.9

1.8

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

868

3588

1.54

29.42

2.8

1.6

0.93

0.80

nmol/l

4.48

713

3009

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

14.77

29.38

10.1

7.9

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

578

2166

1.70

29.09

1.3

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

303

919

2.09

29.04

1.7

1.9

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

214

560

2.43

28.91

1.5

1.4

62.57

62.25

0.04

169

465

(3035880) pH of Pleural fluid

298

906

2.09

28.40

1.3

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1208

5389

1.43

28.15

2.3

2.4

0.04

0.03

g/l

0.26

1111

4915

(4034850) Laboratory test

1231

5532

1.42

27.55

14.8

8.6

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1135

5025

1.44

27.55

2.3

2.4

0.00

g/l

0.49

1039

4564

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

9.61

27.55

11.9

22.6

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1118

4949

1.44

27.16

2.3

2.5

0.00

g/l

-0.00

1035

4551

(3005322) IgE [Units/volume] in Serum or Plasma

1908

9226

1.33

27.12

1.3

237.21

277.06

u/ml

0.86

1749

8521

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

6.02

27.01

3.7

3.0

—

(40768806) Pleura Pathology biopsy report

501

1844

1.73

26.93

1.5

1.6

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

449

1609

1.78

26.47

1.1

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

700

2831

1.58

26.15

1.3

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

196

523

2.38

25.47

2.2

2.3

174.85

153.55

2.19

183

482

(3026389) Candida sp identified in Specimen by Organism specific culture

578

2251

1.63

25.22

1.5

1.3

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

228

656

2.21

24.98

3.2

2.0

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

290

918

2.01

24.90

1.4

1.15

1.24

nmol/l

0.55

213

706

(3049717) Cytology report of Urine Cyto stain

1585

7573

1.34

24.43

2.8

2.7

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1230

5661

1.39

24.02

2.2

2.3

36.91

37.80

g/l

5.59

1095

4843

(3008037) Lactate [Moles/volume] in Venous blood

868

3758

1.47

23.69

4.3

2.7

1.64

1.59

mmol/l

0.74

841

3691

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

7.16

23.60

6.1

4.9

398.40

436.32

umol/l

0.45

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

308

1019

1.92

23.38

1.5

1.4

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

5.86

23.19

11.6

9.6

159.42

250.30

e6/l

0.56

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

19486

116885

1.12

22.97

3.7

3.1

63.46

52.35

u/l

31.15

18040

107790

(3051651) Icteric interference index of Serum or Plasma

292

958

1.94

22.73

4.6

3.6

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1319

6196

1.36

22.72

2.4

2.6

0.74

0.99

g/l

1.77

1159

5255

(43055442) Apixaban [Mass/volume] in Serum or Plasma

194

3.23

22.64

1.5

1.4

124.26

110.08

ug/l

0.54

145

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

171

456

2.38

22.33

3.1

2.1

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

171

456

2.38

22.33

3.1

2.1

—

(40761511) CBC panel - Blood by Automated count

30143

186136

1.18

22.24

22.1

12.3

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

245

761

2.04

22.21

1.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

441

1659

1.69

22.02

1.2

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

308

1041

1.88

21.98

1.2

1.1

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

275

903

1.93

21.39

1.6

1.5

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

276

908

1.93

21.35

1.6

1.5

—

(3003694) ABO and Rh group [Type] in Blood

8092

46159

1.14

21.33

1.3

—

(3051593) INR in Capillary blood by Coagulation assay

250

795

2.00

21.29

11.5

8.5

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

252

810

1.97

20.85

3.3

3.7

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

329

1173

1.78

19.87

1.2

10.36

9.38

mmol/l

3.11

303

1102

(3045414) Leukocytes [Presence] in Urine

1621

8003

1.29

19.78

2.2

1.8

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

397

1497

1.69

19.71

1.5

1.8

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

397

1497

1.69

19.71

1.5

1.8

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

397

1497

1.69

19.71

1.5

1.8

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

558

2293

1.55

19.57

1.1

1.59

1.52

g/l

2.87

509

2052

(3051611) Lipemic interference index of Serum or Plasma

473

1875

1.60

19.35

4.0

3.1

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

102

227

2.85

19.01

1.4

12.33

11.62

0.10

116

(3000034) Microalbumin [Mass/volume] in Urine

440

1726

1.62

18.80

3.2

3.0

82.13

44.31

mg/l

1.28

329

1236

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

350

1293

1.72

18.75

1.3

12.17

15.38

u/l

1.38

318

1207

(3022621) pH of Urine by Test strip

2257

11669

1.24

18.73

3.3

2.9

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1903

9664

1.26

18.50

3.3

2.6

0.31

0.29

e6/l

0.23

1879

9413

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

1048

4908

1.36

18.45

1.9

1.6

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

208

653

2.02

18.43

1.6

27.63

8.27

nmol/l

0.36

177

551

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

853

3870

1.40

18.20

1.4

—

(40768804) Tissue Pathology biopsy report

11108

75611

0.90

18.20

2.1

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

128

330

2.46

18.06

1.1

0.71

0.66

umol/24h

0.39

160

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

454

1814

1.59

18.01

1.5

1.7

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1316

6400

1.31

17.96

1.1

13.15

6.06

u/ml

0.24

(3038515) Glucose [Moles/volume] in Venous blood

800

3598

1.42

17.94

4.5

2.7

8.04

7.54

mmol/l

4.11

778

3543

(3024980) IgG subclass 4 [Mass/volume] in Serum

621

2664

1.48

17.86

1.6

0.80

0.84

g/l

0.24

454

1992

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

531

2213

1.53

17.54

1.3

1.2

4.52

3.58

u/ml

0.84

264

957

(3017704) Immunofixation for Urine

273

957

1.81

17.50

1.4

1.7

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

910

4203

1.38

17.49

1.5

1.3

—

(3048689) Calprotectin [Mass/mass] in Stool

3500

19012

1.18

17.34

2.1

2.2

160.41

144.44

ug/g

1.60

2821

14918

(3014891) Appearance of Pleural fluid

204

2.86

17.30

1.3

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

543

2281

1.51

17.29

1.3

1.2

3.54

3.87

u/ml

0.12

189

786

(3021879) Hepatitis B virus core Ab [Presence] in Serum

2011

10356

1.24

17.29

1.5

1.4

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

120

307

2.48

17.23

1.5

1.3

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

484

1985

1.55

17.20

1.2

57.75

62.10

u/l

0.89

437

1761

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

140

386

2.30

17.12

1.4

1.1

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

169

3.04

16.89

1.2

6.50

383697.58

nmol/l

1.55

141

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

312

3242

0.61

16.71

3.3

3.6

30.26

42.47

u/ml

1.72

298

3152

(3008116) Ketones [Moles/volume] in Urine by Test strip

122

320

2.42

16.65

1.5

1.3

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

849

3919

1.38

16.40

1.2

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

421

1692

1.58

16.35

1.6

1.8

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

116

300

2.45

16.32

5.9

6.4

68.23

73.04

0.93

228

(3037121) Protein [Mass/volume] in Urine

1281

6293

1.30

16.26

3.2

0.42

0.29

g/l

4.28

590

2777

(4062490) Immunoglobulin typing, IgG

410

1640

1.59

16.25

1.5

1.4

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

1380

6849

1.29

16.20

1.3

1.4

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

334

1271

1.67

16.14

1.5

1.4

14.42

12.32

u/l

5.45

323

1221

(3016038) Potassium [Moles/volume] in Urine

308

1153

1.70

15.83

1.2

1.1

35.01

34.07

mmol/l

0.28

267

968

(3027135) IgG subclass 1 [Mass/volume] in Serum

408

1642

1.58

15.78

1.4

7.01

6.84

g/l

0.30

284

1115

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

215

723

1.89

15.75

2.4

2.9

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

407

1640

1.58

15.66

1.4

0.45

0.40

g/l

1.94

286

1119

(3028192) IgG subclass 2 [Mass/volume] in Serum

407

1643

1.57

15.54

1.4

2.84

2.98

g/l

0.96

287

1117

(3011335) Digoxin [Mass/volume] in Serum or Plasma

100

3.61

15.45

2.6

2.0

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

502

4624

0.68

15.29

1.4

1.3

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

680

3061

1.41

15.25

1.5

1.6

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

159

488

2.07

15.07

1.5

1.4

3.27

2.33

0.59

131

417

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1356

10745

0.79

14.96

1.3

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

595

2633

1.44

14.68

1.1

32.33

5302.16

iu/ml

0.66

114

520

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1042

5052

1.31

14.60

1.4

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

580

2557

1.44

14.60

1.1

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

330

1287

1.63

14.56

1.8

1.4

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

250

906

1.75

14.46

1.3

1.2

244.49

356.90

u/l

1.06

226

844

(3047352) Trisomy 18 risk [Likelihood] in Fetus

358

0.12

14.35

1.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

371

0.14

14.31

1.5

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

230

816

1.79

14.29

1.2

—

(3003129) Base excess in Capillary blood by calculation

151

465

2.06

14.22

1.6

1.7

0.52

0.81

mmol/l

0.34

138

440

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

631

2840

1.41

14.20

1.2

—

(3005033) Fetal Nuchal fold Thickness US

356

0.12

14.16

1.4

—

(3020961) Endomysium IgA Ab [Titer] in Serum

1315

6603

1.27

14.09

1.1

210.67

206.90

titre

0.02

169

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1013

4919

1.31

14.05

1.6

7.07

5.54

iu/ml

0.09

228

1044

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

370

1498

1.57

14.01

2.3

—

(40768793) Breast Pathology biopsy report

434

4037

0.68

13.96

1.3

—

(40762365) Oxygen content in Arterial blood by calculation

105

280

2.38

13.92

2.9

3.4

15.39

14.52

ml/dl

2.24

267

(3044927) Protein electrophoresis panel - Urine

452

1916

1.50

13.90

1.2

—

(3041354) Potassium [Moles/volume] in Venous blood

484

2086

1.47

13.73

3.0

2.1

4.12

4.05

mmol/l

2.83

479

2073

(3035285) Chloride [Moles/volume] in Venous blood

484

2086

1.47

13.73

3.0

2.1

105.50

105.47

mmol/l

0.06

479

2073

(3000919) Neutrophils/100 leukocytes in Pleural fluid

143

440

2.06

13.52

1.5

1.3

20.51

22.05

0.26

127

402

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

500

2179

1.46

13.42

1.2

1.1

112.30

120.55

5.55

453

1938

(3009871) Measles virus Ab [Titer] in Serum

148

465

2.02

13.25

1.4

1.8

—

(1617658) Protocol used for examination of sentinel lymph nodes

120

1526

0.50

13.21

1.0

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

196

2.62

13.11

1.3

41.26

426.73

u/l

1.00

144

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

590

2663

1.41

13.11

1.0

1.1

—

(3014051) Protein [Presence] in Urine by Test strip

962

4690

1.31

13.00

2.8

2.5

—

(3011544) Albumin [Mass/volume] in Pleural fluid

154

2.84

12.95

1.1

14.29

18.93

g/l

5.05

132

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

1105

8799

0.79

12.74

3.2

4.0

64.55

64.94

u/ml

0.01

1062

8482

(3035947) Staphylolysin Ab [Units/volume] in Serum

224

818

1.74

12.69

1.2

1.1

5.24

3.60

iu/ml

0.43

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

282

1098

1.63

12.60

1.6

1.4

14.82

12.61

umol/l

4.60

263

1037

(3022145) Colonoscopy Study observation

3773

21122

1.15

12.43

1.3

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

471

2063

1.45

12.36

3.0

2.1

—

(4146454) Self-monitoring of blood glucose

506

2247

1.43

12.34

3.0

2.6

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

547

2464

1.41

12.32

1.1

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

134

2.93

12.32

1.2

1.1

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

735

3480

1.34

12.21

1.3

1.2

9.50

11.87

u/ml

0.13

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

389

1650

1.50

12.01

1.2

1.1

94.01

98.46

2.34

373

1509

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1192

6033

1.26

12.00

1.6

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

252

2.34

11.98

1.4

1.2

100.81

459.83

ng/l

0.59

170

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

408

1749

1.48

11.96

3.5

3.8

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

105

301

2.21

11.90

1.2

1.36

1.88

mmol/l

3.62

186

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

241

2.37

11.90

1.3

1.2

92.98

88.43

0.30

(40758047) Lysozyme [Mass/volume] in Pleural fluid

131

2.90

11.74

1.2

1.1

8.91

9.64

mg/l

0.17

123

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

296

1190

1.58

11.65

1.4

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

188

670

1.78

11.62

1.8

88.51

116.11

umol/l

1.01

350

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

1026

0.43

11.52

1.1

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

471

2094

1.43

11.45

2.2

2.4

7.18

6.73

titre

0.03

(3020191) Ethanol [Moles/volume] in Serum or Plasma

341

1425

1.52

11.33

1.5

1.35

1.42

promille

0.35

259

1119

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

505

2284

1.40

11.17

1.2

1.1

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

318

1314

1.54

11.13

1.2

159.62

165.35

titre

0.05

226

(3035637) Corticotropin [Mass/volume] in Plasma

475

2129

1.42

11.06

1.5

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

321

1332

1.53

11.03

1.2

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

317

1312

1.53

11.02

1.2

110.00

172.26

titre

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

11.60

11.02

3.0

2.1

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

121

379

2.02

11.01

1.1

1.2

98.60

108.50

1.68

111

351

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

456

0.18

10.99

1.5

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

121

380

2.02

10.94

1.1

78.10

89.58

3.01

171

(3035320) C reactive protein [Mass/volume] in Body fluid

303

1245

1.54

10.89

2.9

2.4

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

287

1169

1.56

10.73

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

426

0.16

10.73

1.5

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

425

0.16

10.69

1.5

1.4

—

(3052592) Norovirus Ag [Presence] in Stool

104

311

2.12

10.69

1.4

1.3

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

447

1995

1.42

10.68

1.3

1.2

61.72

58.21

u/ml

0.11

118

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

424

0.16

10.66

1.5

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

424

0.16

10.66

1.5

1.4

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

723

3487

1.32

10.65

1.3

1.2

5.53

6.50

u/ml

0.12

244

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

610

2872

1.35

10.58

1.3

1.2

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

150

514

1.85

10.56

1.2

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

117

368

2.01

10.55

1.1

1.2

76.68

90.93

2.74

166

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

244

2.26

10.44

1.3

1.1

79.51

81.09

0.10

(40768800) Prostate Pathology biopsy report

577

4865

0.75

10.39

1.2

—

(3020491) Glucose [Moles/volume] in Blood

300

1244

1.53

10.37

2.0

1.8

7.77

7.11

mmol/l

2.49

212

849

(36660697) Celiac disease serology panel - Serum

2305

12617

1.17

10.30

1.2

1.1

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

164

2.55

10.25

1.2

1.1

16.46

20.20

u/l

1.14

112

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

112

351

2.02

10.22

1.2

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

125

2.79

10.09

1.2

86.67

124.86

ug/l

1.30

(3047189) Immunofixation for 24 hour Urine

221

860

1.63

10.02

1.7

1.8

—

(3002079) Sodium [Moles/time] in 24 hour Urine

192

720

1.69

10.02

1.2

164.10

162.12

mmol/24h

0.10

192

720

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

466

2124

1.39

9.92

1.1

—

(4035726) Immunohistochemistry procedure

2535

18274

0.87

9.90

1.5

1.4

—

(3050129) First trimester maternal screen panel - Serum or Plasma

506

0.26

9.83

1.8

1.4

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

128

427

1.90

9.82

1.4

26.64

22.14

0.87

102

366

(3000475) Leukocytes [#/volume] in Synovial fluid

927

4672

1.26

9.76

1.6

14597.96

13231.57

e6/l

0.34

667

3336

(3013139) Helicobacter pylori Ag [Presence] in Stool

2096

11438

1.17

9.74

1.2

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

353

3177

0.70

9.63

1.5

1.9

—

(3012898) Urea [Moles/volume] in Urine

151

2.56

9.57

1.5

1.3

135.02

175.76

mmol/l

2.14

136

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

137

472

1.84

9.54

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

117

383

1.94

9.50

1.2

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

171

2.44

9.45

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

275

1145

1.52

9.39

1.1

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

843

4221

1.27

9.39

1.3

6.50

6.84

u/ml

0.08

135

664

(3010144) Erythrocytes [#/volume] in Synovial fluid

392

1752

1.42

9.36

1.3

1.4

142677.78

105102.11

e6/l

0.41

258

1188

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

170

630

1.71

9.30

1.2

1.1

5.41

13.81

u/ml

0.56

(3037692) Legionella sp identified in Specimen by Organism specific culture

163

597

1.73

9.29

1.7

1.2

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

900

4555

1.26

9.17

1.3

1.2

40.62

40.63

u/ml

0.00

258

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

201

783

1.63

9.13

2.5

2.3

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

158

577

1.74

9.11

1.1

1688.01

1514.05

miu/ml

1.09

158

577

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

238

967

1.56

9.08

1.6

1.4

7.64

5.85

u/l

1.02

206

811

(42529582) MDA5 Ab [Presence] in Serum by Line blot

114

377

1.92

9.01

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

114

377

1.92

9.01

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

114

377

1.92

9.01

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

114

377

1.92

9.01

1.1

—

(3000330) Specific gravity of Urine by Test strip

1701

9186

1.18

9.01

4.0

3.3

—

(40757373) Influenza virus identified in Isolate

304

2.02

8.92

1.6

1.3

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

124

2.65

8.80

1.5

2.6

0.99

1.03

mmol/l

0.05

(44816559) Phosphatidylethanol [Mass/volume] in Blood

591

2852

1.32

8.76

1.4

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

827

4169

1.26

8.74

1.3

1.2

5.63

5.99

u/ml

0.07

411

(3044416) Complement C4 [Mass/volume] in Pleural fluid

3.36

8.71

1.2

1.3

0.06

0.07

g/l

0.64

(3023487) Leukocytes [#/volume] in Peritoneal fluid

182

700

1.65

8.71

2.0

1.8

3591.83

1776.42

e6/l

0.29

126

465

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

253

1053

1.52

8.69

1.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

127

441

1.82

8.68

1.1

—

(3000963) Hemoglobin [Mass/volume] in Blood

31349

200490

0.89

8.66

33.8

19.8

133.14

136.63

g/l

267.18

31010

197008

(3003327) Ova and parasites identified in Stool by Light microscopy

1007

5197

1.23

8.63

1.6

1.7

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

107

352

1.93

8.61

2.6

2.3

7.82

7.37

mmol/l

0.57

225

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

253

1057

1.52

8.55

1.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

204

2.23

8.53

2.5

1.4

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

164

618

1.68

8.49

1.8

1.7

17545.65

7196.97

e6/l

0.99

328

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

266

1126

1.50

8.46

1.2

30.60

24.87

u/l

0.81

225

948

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

713

5685

0.79

8.43

1.9

1.5

5.41

3.47

mg/l

2.33

571

4158

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

272

1158

1.49

8.42

1.2

98.66

88.08

u/l

0.82

235

998

(3034426) Prothrombin time (PT)

134

478

1.78

8.41

1.3

1.2

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

3554

20301

1.12

8.39

1.8

1.62

1.50

11.84

3014

17653

(3026361) Erythrocytes [#/volume] in Blood

31347

200441

0.89

8.38

33.6

19.7

4.41

4.52

e12/l

204.01

30616

193347

(3024731) MCV [Entitic volume]

31346

200431

0.89

8.36

33.5

19.6

91.62

91.30

28.26

31009

196913

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

159

597

1.69

8.35

1.9

1.6

77910.96

18383.22

u/ml

0.55

(3010813) Leukocytes [#/volume] in Blood

31347

200435

0.89

8.34

33.6

19.7

7.16

6.64

e9/l

217.23

30626

193348

(3042010) Triglyceride [Moles/volume] in Pleural fluid

252

2.09

8.32

1.3

1.2

0.77

1.85

mmol/l

1.53

170

(3008295) Osmolality of Serum or Plasma

386

1763

1.39

8.21

1.4

1.3

279.50

277.63

mosm/kgh2o

0.73

317

1343

(3039443) Prostate specific Ag panel - Serum or Plasma

594

4823

0.78

8.18

1.6

1.7

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

168

644

1.65

8.18

1.2

—

(3035941) MCH [Entitic mass]

31344

200392

0.89

8.16

33.4

19.6

30.41

30.43

1.13

31009

196884

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

230

952

1.53

8.14

1.1

38.81

22.47

u/l

2.09

212

849

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

230

953

1.53

8.11

1.1

108.09

81.91

u/l

2.40

214

852

(3026692) Albumin [Mass/volume] in Peritoneal fluid

133

479

1.76

8.10

1.4

1.3

17.06

11.82

g/l

8.71

104

357

(3004809) Band form neutrophils/100 leukocytes in Blood

642

3168

1.29

8.10

3.4

1.37

1.62

0.97

573

2791

(3022689) Creatine [Moles/volume] in Urine

147

545

1.71

8.10

1.5

—

(3044007) Cell count panel - Peritoneal fluid

148

551

1.70

8.04

2.0

1.8

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

171

1701

0.63

7.87

1.3

161.48

176.50

pmol/l

0.91

171

1701

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

285

2561

0.70

7.81

1.5

1.9

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

399

1850

1.37

7.78

1.1

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

294

1293

1.44

7.76

1.0

1.1

291.43

285.37

mg/l

0.69

264

1145

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

4.58

7.75

3.2

3.4

—

(3027944) Amphetamines [Presence] in Urine

389

3316

0.74

7.68

2.4

1.8

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

309

1.93

7.64

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

122

438

1.76

7.55

1.7

1.9

—

(3028300) Cannabinoids [Presence] in Urine

402

3400

0.74

7.53

2.3

1.8

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

138

514

1.70

7.51

1.3

1.5

15.54

15.16

pmol/l

0.37

117

422

(3027008) Opiates [Presence] in Urine

401

3388

0.75

7.47

2.2

1.8

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

317

1.90

7.41

1.2

1.3

56.52

15.80

mg/l

0.32

234

(3007461) Platelets [#/volume] in Blood

31346

200296

0.90

7.39

33.6

19.7

239.90

249.22

e9/l

112.17

30742

193942

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

160

2.29

7.36

1.1

1.90

1.66

umol/24h

0.88

160

(3000764) Benzodiazepines [Presence] in Urine

400

3371

0.75

7.33

2.3

1.9

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

193

2.17

7.32

1.4

72.98

71.91

0.10

161

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

149

573

1.65

7.23

1.8

1.6

22.31

467.74

ug/l

1.62

141

542

(3013166) Neutrophils/100 leukocytes in Synovial fluid

138

523

1.67

7.08

1.3

1.4

67.84

53.77

4.60

112

448

(44786800) Granulocytes/100 leukocytes in Body fluid

226

2.05

7.03

1.3

1.4

21.21

27.19

0.77

185

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

641

3229

1.26

6.92

1.3

1.2

47.13

46.47

u/ml

0.04

306

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

294

1.90

6.87

1.1

7.04

8.54

pmol/l

0.08

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

436

3590

0.77

6.78

1.4

156.13

173.71

pmol/l

0.51

424

3503

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

265

1175

1.43

6.76

1.5

1.6

9.78

6.16

u/l

2.17

201

941

(3020564) Creatinine [Moles/volume] in Serum or Plasma

30998

193911

1.10

6.74

27.4

15.6

87.86

77.44

umol/l

237.53

30992

193834

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

198

830

1.51

6.71

1.1

1.06

1.07

ratio

0.17

286

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

364

1706

1.35

6.70

1.5

23.91

31.47

4.07

237

1035

(3033799) Differential panel - Peritoneal fluid

153

605

1.60

6.69

2.0

1.8

—

(3009542) Hematocrit [Volume Fraction] of Blood

31344

200171

0.91

6.63

34.1

19.7

39.68

40.57

34.00

29052

186544

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

517

2553

1.29

6.59

1.9

25.25

24.96

ug/l

0.03

502

2501

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

4.08

6.50

1.1

1.4

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

117

435

1.70

6.48

1.5

1.3

28.74

42.20

g/l

0.45

321

(3016879) Cocaine [Presence] in Urine

383

3181

0.76

6.38

2.3

1.9

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

147

2.24

6.30

1.4

1.6

50.96

44.41

umol/l

0.60

147

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

3653

25116

0.91

6.23

6.0

4.5

33.66

31.84

18.96

2872

16057

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

318

1480

1.36

6.17

1.8

1.9

4.53

3.77

mg/l

1.78

302

1414

(3044941) Cell count panel - Synovial fluid

594

3015

1.25

6.07

1.4

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

517

2588

1.27

5.95

1.6

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

198

856

1.47

5.84

1.3

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

198

857

1.46

5.81

1.3

1.5

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

132

2.25

5.81

1.4

1.1

14.02

18.15

pmol/l

0.38

114

(3019832) Treponema pallidum Ab [Presence] in Serum

1119

6066

1.17

5.79

1.7

1.5

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

2.90

5.67

1.2

7832.00

1411.50

ng/l

1.38

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

3.93

5.60

1.1

1.2

—

(1761868) Lipid panel - Serum or Plasma

9450

62460

0.94

5.58

4.0

2.8

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

296

1388

1.35

5.52

1.6

25.41

25.17

u/ml

0.02

296

(3023323) Follitropin [Units/volume] in Serum or Plasma

486

3828

0.80

5.34

1.4

1.3

29.08

35.60

iu/l

3.56

407

3247

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

756

0.56

5.29

1.5

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

216

972

1.41

5.20

2.0

1.8

2.28

2.21

u/field

0.05

162

694

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

114

450

1.60

5.13

1.3

37.32

39.06

0.17

299

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

27896

174129

1.07

5.11

21.2

12.7

74.35

79.33

ml/min/173m2

260.93

24094

142502

(3023383) Lactate [Moles/volume] in Pleural fluid

139

576

1.53

5.09

1.4

1.3

3.31

3.73

mmol/l

0.89

122

533

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

15845

97417

1.05

5.04

2.5

2.4

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

476

2412

1.25

5.02

2.4

1.9

26.51

28.49

mg/l

0.28

123

621

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

173

753

1.46

5.00

1.1

1.0

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

465

2352

1.25

4.99

1.5

61.11

57.29

1.23

301

1484

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

146

616

1.50

4.93

1.1

95.44

100.88

1.43

108

493

(3002256) Pathology report gross observation

3658

24891

0.92

4.91

1.3

—

(3025130) Human papilloma virus identified in Specimen

177

1580

0.71

4.86

1.6

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

264

1245

1.34

4.81

1.2

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

2.53

4.79

1.2

1.1

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

144

2.07

4.78

1.1

21.33

15.30

iu/ml

0.20

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

284

1.74

4.77

1.1

1.2

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

30948

193975

1.08

4.76

14.1

10.3

28.81

26.57

u/l

17.41

30050

186161

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

149

2.04

4.72

1.2

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

200

905

1.40

4.71

1.4

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

200

905

1.40

4.71

1.4

1.5

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

724

3863

1.19

4.62

1.6

1.8

18.20

12.95

iu/l

0.13

218

1285

(21494434) Karyotype in Bone marrow

335

1646

1.29

4.59

1.2

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

254

1201

1.34

4.58

1.3

408.12

479.67

titre

0.08

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

212

975

1.38

4.56

1.1

10.94

5.89

nmol/l

0.65

199

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

119

491

1.53

4.50

1.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

322

2595

0.78

4.40

2.5

1.9

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

232

1094

1.34

4.29

1.4

1.3

1.47

1.56

g/l

5.40

232

1094

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

178

811

1.39

4.09

1.3

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

111

463

1.52

4.04

1.8

1.3

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

459

2379

1.22

4.03

1.4

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

6.33

3.95

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

215

1017

1.34

3.93

1.2

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

459

2387

1.22

3.91

1.4

1.5

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

295

1459

1.28

3.91

2.1

2.0

1.92

2.57

u/field

1.00

139

596

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

614

0.59

3.91

3.0

2.5

119.11

152.30

nmol/l

1.82

526

(3045424) Erythrocytes [Presence] in Urine

590

3143

1.19

3.90

1.7

1.4

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

332

1667

1.26

3.90

1.2

1.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1131

8064

0.88

3.89

1.5

1.7

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

280

1377

1.29

3.88

1.6

2.0

1676.02

2149.75

u/l

0.19

480

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

733

3982

1.17

3.84

1.2

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

213

1011

1.33

3.82

1.2

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

882

0.66

3.81

13.2

12.4

0.65

0.64

mmol/l

0.27

802

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

742

0.63

3.78

1.1

1.2

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

2.18

3.77

5.7

4.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

454

3455

0.83

3.69

1.4

1.5

—

(4281824) Cell count and differential, peritoneal fluid

267

2149

0.78

3.68

1.2

1.1

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

167

768

1.38

3.68

1.3

1.2

6.07

6.11

mmol/l

0.21

151

731

(3025468) Yersinia sp identified in Specimen by Organism specific culture

452

2364

1.21

3.67

1.4

1.5

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

190

893

1.35

3.66

4.1

3.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

246

1202

1.30

3.62

1.2

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

451

2363

1.21

3.60

1.4

1.5

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

247

1209

1.29

3.59

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

246

1204

1.29

3.58

1.2

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

465

2446

1.21

3.57

1.4

1.5

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

247

1210

1.29

3.57

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

247

1210

1.29

3.57

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

246

1205

1.29

3.56

1.2

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

451

2367

1.21

3.55

1.4

1.5

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

235

1146

1.30

3.52

1.9

2.1

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

240

1175

1.29

3.49

1.3

125.62

61.40

titre

0.37

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

243

1.67

3.48

1.0

1.1

—

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

2.43

3.45

1.3

1.1

166.83

180.21

ug/g

0.14

(40761539) Cells [Type] in Urine sediment by Light microscopy

105

450

1.48

3.42

1.3

1.2

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

352

1809

1.23

3.42

1.1

1.82

2.11

iu/ml

—

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

2.19

3.37

1.0

1.1

—

362.00

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.19

3.37

1.1

1.0

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

231

1.67

3.36

1.0

1.1

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

4.87

3.33

1.1

1.0

—

(3032057) Clostridioides difficile [Presence] in Stool

418

1.48

3.29

1.8

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

6.33

3.26

1.1

1.0

—

(3020618) Glucose [Moles/volume] in Synovial fluid

2.46

3.25

1.0

1.1

6.14

5.27

mmol/l

0.36

(3006270) Folate [Moles/volume] in Blood

293

1485

1.25

3.25

1.2

361.48

356.61

nmol/l

0.12

239

1253

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

2.30

3.24

1.2

1.1

230.72

528.59

u/l

0.88

(3002621) Streptococcal DNAse B [Units/volume] in Serum

126

1.91

3.23

1.1

1.0

—

(3003338) MCHC [Mass/volume]

23961

149522

1.04

3.21

30.1

17.3

331.47

332.65

g/l

70.50

23774

148457

(3011288) Drugs identified in Urine by Screen method

271

2138

0.80

3.20

2.5

2.7

—

(3024263) Appearance of Synovial fluid

208

1014

1.30

3.17

1.3

1.4

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

305

1.56

3.14

1.7

1.6

—

(3013293) Extractable nuclear Ab [Presence] in Serum

231

1.64

3.14

1.6

1.5

—

(3000285) Sodium [Moles/volume] in Blood

217

1.66

3.11

1.2

—

(3018133) Calcium [Moles/volume] in Urine

222

1.65

3.10

1.4

1.6

2.27

2.64

mmol/l

0.76

196

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

120

1.90

3.04

1.2

1.0

11.67

11.57

u/l

0.01

120

(3046861) Legionella sp Ag [Presence] in Urine

2.08

3.03

1.3

1.1

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

2.02

3.00

1.1

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

121

1.88

2.97

3.5

5.2

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

155

733

1.34

2.95

1.4

1.6

14.66

13.92

umol/l

0.05

536

(3006462) Nitrate [Presence] in Urine

179

865

1.31

2.94

3.0

3.3

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

214

1711

0.79

2.89

4.6

2.8

13.47

13.24

2.05

208

1682

(3023420) DNA double strand Ab [Units/volume] in Serum

345

1805

1.21

2.89

1.7

1.4

27.05

27.18

iu/ml

0.01

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

420

1.45

2.89

2.1

2.5

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

145

0.35

2.88

5.0

7.3

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

123

563

1.38

2.88

2.0

—

(3010838) Calcium [Moles/time] in 24 hour Urine

606

3327

1.15

2.88

1.8

1.9

4.45

5.26

mmol/24h

6.79

530

2894

(3015076) Soybean IgE Ab [Units/volume] in Serum

619

0.65

2.87

1.1

1.0

0.26

0.81

u/ml

0.57

158

(3028433) Virus identified in Specimen by Culture

129

596

1.37

2.86

1.2

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

151

1260

0.76

2.86

1.5

1.4

0.19

0.23

nmol/l

0.70

100

885

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

186

1509

0.78

2.84

4.5

5.2

111.43

119.42

u/ml

0.03

442

(3032743) Legionella sp IgG Ab [Presence] in Serum

114

1.89

2.84

1.1

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

147

1.77

2.79

2.5

1.9

67.90

58.02

1.02

(3001686) Cold agglutinin [Titer] in Serum or Plasma

317

1.50

2.70

1.1

1.4

55.60

126.39

titre

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

797

0.71

2.69

1.4

1.5

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

116

533

1.38

2.68

1.3

137.66

338.86

ug/l

1.07

310

(3020717) Zinc [Moles/volume] in Serum or Plasma

153

734

1.32

2.68

1.3

1.5

18.76

25.81

umol/l

2.62

141

695

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

135

1.78

2.68

1.2

—

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

2.37

2.63

1.2

1.4

105.80

107.81

ug/l

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

2.01

2.59

1.3

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

146

1.73

2.59

1.1

1.2

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

118

1.82

2.59

2.1

1.9

16.50

19.86

0.23

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

118

1.82

2.59

1.4

1.5

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

156

1275

0.77

2.57

1.0

0.96

0.48

u/ml

0.29

347

(3047185) IgG [Mass/volume] in Urine

2.56

2.55

1.0

1.1

—

41.97

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

115

533

1.37

2.54

1.8

2.1

36.03

45.94

u/l

0.24

105

484

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1038

7238

0.90

2.53

1.4

1.7

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

119

1.81

2.53

1.1

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

175

0.40

2.52

1.0

—

(3036603) Volume of Urine

248

1276

1.23

2.50

1.5

1.6

1837.41

1896.78

0.53

235

1238

(21491868) Cryoglobulin [Mass/volume] in Serum

125

589

1.34

2.50

1.2

0.10

0.82

g/l

2.42

(3010726) Horse dander IgE Ab [Units/volume] in Serum

232

1803

0.81

2.48

1.0

1.1

1.50

1.19

u/ml

0.33

110

842

(3021788) Differential panel - Synovial fluid

649

3623

1.14

2.48

1.5

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

752

4238

1.13

2.46

1.4

1.3

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

107

494

1.37

2.44

1.3

1.2

113.99

113.00

0.13

446

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

274

1.50

2.41

1.0

—

(44813793) Dust mix specific IgE antibody measurement

202

1021

1.25

2.41

1.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

403

2180

1.17

2.39

3.9

3.7

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

377

2030

1.18

2.37

1.2

7.66

7.59

mmol/l

0.18

328

1749

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

2.14

2.37

1.0

1.1

1.08

1.36

u/field

0.19

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

112

525

1.35

2.34

1.3

0.32

0.31

g/l

0.38

429

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

131

1078

0.77

2.31

4.5

5.8

1660.00

3683.20

u/ml

0.26

215

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.86

2.31

1.0

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

700

0.71

2.30

1.1

1.0

3.02

0.57

u/ml

0.58

167

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

129

1060

0.77

2.26

1.4

1.7

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

175

0.43

2.26

1.1

1.2

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

274

1.48

2.23

1.6

1.7

71.62

54.87

pmol/l

0.35

230

(3003740) Influenza virus B Ag [Presence] in Specimen

277

2090

0.84

2.22

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

277

2086

0.84

2.18

1.1

—

(3004616) Nuclear Ab [Presence] in Serum

400

2182

1.16

2.17

1.3

—

(40768795) Lymph node Pathology biopsy report

271

2044

0.84

2.17

1.1

1.2

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

250

1.49

2.17

1.4

1.2

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

630

3547

1.13

2.15

1.4

9.70

9.91

u/l

0.14

511

2864

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

1.81

2.12

1.1

1.06

1.05

u/field

0.04

(3007463) Buprenorphine [Presence] in Urine

3.16

2.12

11.7

7.2

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

241

1.50

2.12

3.5

3.3

43.52

41.58

umol/l

0.27

213

(3024869) Neuronal Ab [Presence] in Serum

374

1.39

2.07

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

271

1441

1.19

2.03

1.0

1.1

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

1.95

2.00

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

277

2065

0.85

1.97

1.0

1.1

2.81

3.43

u/ml

0.45

124

967

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.11

1.97

1.1

1.0

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

268

1429

1.19

1.96

1.2

46.36

43.62

u/ml

0.07

102

(3019174) dRVVT (LA screen)

125

1.67

1.95

1.2

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

2.00

1.94

1.1

1.0

74.67

136.64

pmol/l

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

403

0.66

1.93

2.3

2.0

2.80

9.51

ug/l

1.25

213

(1175426) CD3 cells/100 lymphocytes in Blood

237

1252

1.20

1.92

1.8

2.1

71.91

71.65

0.09

222

1196

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

193

1000

1.22

1.91

1.6

2.0

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

193

1000

1.22

1.91

1.6

2.0

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

107

1.71

1.88

1.3

1.1

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

737

4226

1.11

1.86

1.9

197.00

205.04

pmol/l

1.25

696

4006

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

444

0.68

1.85

1.9

1.8

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

204

1550

0.83

1.83

1.0

4.98

3.16

u/ml

0.77

680

(3016228) CD19 cells/100 cells in Blood

140

704

1.26

1.83

1.9

2.1

8.78

8.49

0.09

135

687

(3001186) Copper [Moles/volume] in Serum or Plasma

383

1.36

1.83

1.2

16.47

16.61

umol/l

0.09

334

(3038026) Centromere Ab [Units/volume] in Serum

273

1469

1.18

1.82

1.2

28.00

63.37

u/ml

1.20

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

1.82

1.81

1.8

1.4

25.56

23.59

mmol/l

0.79

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

261

1.43

1.80

1.1

1.2

—

(3036670) Protein [Mass/volume] in Synovial fluid

117

577

1.28

1.80

1.2

1.3

40.35

40.18

g/l

0.04

307

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

500

0.71

1.78

2.1

1.8

7.95

9.25

mg/l

1.22

394

(3023430) Cat dander IgE Ab [Units/volume] in Serum

191

1455

0.83

1.78

1.0

2.23

3.29

u/ml

0.87

544

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

265

1426

1.18

1.77

1.2

50.91

90.42

u/ml

1.20

(3035933) Granulocytes/100 leukocytes in Blood

387

0.67

1.77

1.4

1.6

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

268

1982

0.85

1.77

1.0

1.17

1.16

u/ml

0.01

776

(3016018) Differential panel - Cerebral spinal fluid

273

2016

0.86

1.77

1.3

1.4

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

315

2300

0.87

1.76

1.1

2.67

1.52

u/ml

0.72

156

1116

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

219

1162

1.19

1.73

1.5

2.0

15.91

16.26

nmol/l

0.29

204

1077

(3001729) Color of Synovial fluid

150

1.56

1.71

1.4

1.7

—

(3011412) CD3 cells [#/volume] in Blood

300

1637

1.16

1.70

2.0

2.5

0.96

1.20

e9/l

2.89

270

1485

(3004347) Hepatitis D virus Ab [Presence] in Serum

2.30

1.70

1.0

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

2.30

1.70

1.3

1.0

2.17

2.52

0.22

(3017354) Segmented neutrophils/100 leukocytes in Blood

365

2021

1.14

1.69

3.2

3.4

60.32

56.45

2.77

309

1695

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

252

1357

1.18

1.69

1.2

2.48

7.55

u/ml

1.21

(3002619) Bacteria identified in Specimen by Culture

389

1.33

1.68

1.3

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

230

1231

1.18

1.66

1.8

2.1

16.13

16.39

0.13

220

1191

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

144

1118

0.81

1.65

5.5

6.6

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

235

1.43

1.63

1.3

1.6

—

(21494814) CD8 cells/100 lymphocytes in Specimen

135

688

1.24

1.61

1.9

2.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

160

0.51

1.60

1.0

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1830

12215

0.94

1.55

2.4

28.51

24.51

au/ml

0.55

874

(3014271) Vancomycin [Susceptibility]

197

1048

1.19

1.55

3.0

2.9

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

461

1.29

1.55

1.1

1.2

321.12

288.18

pmol/l

0.17

331

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

200

1066

1.19

1.54

2.5

2.8

38.19

37.87

0.08

127

549

(37019676) Renin [Units/volume] in Plasma --supine

2.11

1.54

1.0

84.65

19.65

mu/l

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

506

2882

1.11

1.52

1.2

1.3

154.75

205.88

miu/ml

1.88

109

1183

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.75

1.50

1.0

—

(3029075) Extractable nuclear Ab panel - Serum

475

1.28

1.49

1.1

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

196

0.58

1.48

1.1

—

(3010503) CD19 cells [#/volume] in Blood

204

1094

1.18

1.48

2.2

2.7

0.23

0.40

e9/l

0.63

196

1062

(3034614) HLA Ag [Interpretation]

2.48

1.48

1.8

1.2

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

518

0.74

1.47

1.1

1.3

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

360

1.32

1.46

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

827

4832

1.08

1.46

1.8

1.7

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

295

1.35

1.45

1.1

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

156

819

1.21

1.44

1.2

60.59

57.14

0.16

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

312

1.34

1.43

1.9

3.1

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

117

1.57

1.41

1.3

45.81

50.77

mg/l

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

136

0.51

1.40

3.3

2.8

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

100

502

1.26

1.40

1.7

1.6

9.39

9.28

ug/l

0.09

100

502

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

135

0.52

1.38

6.5

5.7

—

(3016244) Insulin [Units/volume] in Serum or Plasma

145

760

1.21

1.38

2.5

3.2

26.06

26.73

mu/l

0.07

135

711

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

385

2175

1.12

1.37

1.1

—

(3015183) Erythrocyte sedimentation rate

745

0.80

1.36

1.2

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

699

4071

1.09

1.36

1.1

13.53

7.50

u/ml

0.63

442

(3023410) Appearance of Cerebral spinal fluid

252

1827

0.87

1.35

1.4

1.5

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

134

699

1.21

1.34

3.1

3.0

29.66

28.37

umol/l

0.56

544

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

2.71

1.34

1.0

1.1

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.93

1.34

1.0

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

100

506

1.25

1.33

1.1

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

141

0.54

1.32

1.0

—

(3045142) Bone marrow Pathology biopsy report

391

2220

1.12

1.29

1.3

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

318

1.31

1.29

1.2

—

(3042517) Benzodiazepines panel - Urine

1.62

1.28

6.3

2.4

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

164

877

1.18

1.28

1.6

1.4

3.34

4.18

0.41

183

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

123

0.51

1.28

1.0

1.1

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

1.88

1.27

1.1

1.2

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1668

11083

0.95

1.25

1.3

59.04

55.15

au/ml

0.22

624

(3021691) Plasmodium malariae Ab [Titer] in Serum

2.88

1.25

2.0

2.3

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

438

2509

1.11

1.24

1.3

1.2

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

401

0.74

1.22

1.7

1.6

73.18

85.92

au/ml

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

3315

21680

0.96

1.22

3.3

4.3

22.93

27.38

ug/l

0.29

2700

17822

(3019420) Tryptase [Mass/volume] in Serum or Plasma

153

818

1.18

1.21

1.5

1.6

11.20

8.46

ug/l

0.49

138

748

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

205

1492

0.87

1.20

1.2

—

(3025296) Carrot IgE Ab [Units/volume] in Serum

0.00

1.20

0.0

1.0

—

0.43

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

113

863

0.83

1.19

1.5

1.3

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

128

1.48

1.18

1.4

1.8

1.11

0.61

0.45

102

(3044009) aPTT.lupus sensitive (LA screen)

128

1.48

1.18

1.3

1.2

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

402

2300

1.11

1.18

3.3

3.4

7.03

8.28

nmol/l

0.20

386

2242

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

318

0.72

1.17

3.0

3.1

61.64

137.51

ng/l

1.63

(3032352) Blasts [#/volume] in Cerebral spinal fluid

213

0.65

1.16

1.1

1.8

—

(40763629) HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method

2.64

1.15

1.0

1.2

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

385

2688

0.90

1.14

4.5

5.0

343.64

363.33

umol/l

2.04

335

2288

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

103

790

0.82

1.14

1.1

477.92

561.73

ng/l

0.09

199

(40768443) Skin Pathology biopsy report

1409

8469

1.05

1.14

1.2

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

271

0.70

1.12

1.5

1.6

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

388

1.26

1.11

1.1

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.55

1.10

1.4

1.6

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

197

1427

0.87

1.10

1.3

32.39

34.55

u/l

0.40

160

1150

(3045683) HLA typing for celiac disease panel - Blood or Tissue

151

815

1.17

1.09

1.0

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

194

0.65

1.08

1.3

2.0

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

135

723

1.18

1.08

1.9

2.3

58.31

52.66

umol/l

0.87

102

608

(3048879) Bone marrow aspiration report

117

619

1.20

1.07

1.5

1.8

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

339

0.75

1.03

1.5

2.2

—

(3008536) Aspergillus sp Ab [Presence] in Serum

375

1.25

1.03

1.6

2.3

—

(3044290) Cell count panel - Cerebral spinal fluid

547

3737

0.92

1.03

1.2

1.4

—

(3041806) Other cells [#/volume] in Blood by Manual count

0.51

1.02

1.9

1.6

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

459

0.79

1.01

1.2

1.1

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

1.01

0.0

1.1

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

103

543

1.20

1.00

1.3

1.2

23.50

25.60

0.10

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

1.50

0.98

1.0

1.1

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

2.01

0.98

1.3

1.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

203

1132

1.14

0.98

1.3

2.00

1.44

u/ml

0.31

114

660

(3047007) Chlamydophila sp Ab [Presence] in Serum

371

2140

1.10

0.98

1.2

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.53

0.97

1.0

1.2

—

(3006567) Chloride [Moles/time] in 24 hour Urine

1.84

0.97

1.2

1.1

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.63

0.96

1.1

241.25

291.26

nmol/l

0.58

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

255

1.29

0.96

2.6

2.5

70.56

64.39

pmol/l

0.29

221

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

386

1.23

0.93

1.2

—

(3008898) HLA-B27 [Presence]

672

4533

0.94

0.92

1.0

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

252

0.73

0.91

1.2

1.5

—

(3009015) Lactate [Moles/volume] in Synovial fluid

213

1.31

0.90

1.2

1.3

6.57

6.62

mmol/l

0.02

102

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.52

0.88

12.2

7.9

—

(3036071) Salmonella sp Ab [Titer] in Serum

477

1.19

0.86

1.1

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

2.00

0.85

1.8

3.6

1.81

1.34

mu/l

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

193

1.31

0.85

1.1

1.0

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

3475

22543

0.97

0.84

1.4

1.3

—

(3028707) Methadone [Presence] in Urine by Screen method

211

1487

0.90

0.82

2.9

2.4

—

(3009208) Meadow Fescue IgE Ab [Units/volume] in Serum

0.00

0.81

0.0

1.0

—

7.80

—

(3023511) Choriogonadotropin [Units/volume] in Urine

541

0.83

0.81

1.3

—

(3009992) Blasts/100 cells in Bone marrow

0.00

0.80

0.0

1.7

—

12.67

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

221

1259

1.11

0.79

2.1

1.6

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

406

1.20

0.79

1.0

1.1

—

(46235168) Fasting glucose [Moles/volume] in Blood

209

0.73

0.79

1.6

2.3

8.82

6.91

mmol/l

1.94

(3020874) Milk IgE Ab [Units/volume] in Serum

710

0.85

0.78

1.0

0.67

0.98

u/ml

0.31

224

(3007733) Chloride [Moles/volume] in Urine

1.78

0.78

1.1

1.2

86.89

77.08

mmol/l

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

243

0.75

1.0

0.33

1.91

u/ml

0.78

197

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

119

655

1.15

0.75

1.6

1.4

1710520.00

2229030.19

iu/ml

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1266

7690

1.04

0.75

1.1

1.0

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

203

1.28

0.75

2.2

2.0

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

131

1.35

0.74

1.4

1.5

38.50

37.40

0.05

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

1.84

0.74

1.0

1.1

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

1.84

0.74

1.0

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

102

0.62

0.73

1.4

1.0

7.39

8.82

mmol/l

—

102

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.62

0.72

1.0

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

224

1558

0.91

0.71

1.1

—

(40762887) Creatinine [Moles/volume] in Blood

1.58

0.71

1.0

1.2

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

205

1.27

0.70

1.1

1.0

101.51

84.89

ug/l

0.94

156

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

6838

42604

1.02

0.70

2.8

3.0

0.72

0.77

ug/l

2.14

4608

27589

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

211

1.26

0.69

2.2

2.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

1.70

0.69

1.3

1.4

1.89

2.27

mmol/24h

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

138

0.69

1.0

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.52

0.68

1.2

1.0

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

1.86

0.67

1.0

1.1

—

(36303858) Crystals [Presence] in Urine

1.64

0.66

1.0

1.2

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

112

1.36

0.66

1.7

1.2

0.15

0.16

nmol/l

0.15

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

405

0.83

0.66

1.2

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

283

1937

0.92

0.65

1.1

4.48

3.57

u/ml

0.28

826

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

154

874

1.11

0.64

1.1

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

0.62

0.0

1.0

—

(36304315) Certolizumab Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.62

0.0

1.3

—

704.20

—

(40758358) Immune stain study

0.63

0.62

1.0

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

465

1.16

0.62

1.1

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

206

0.77

0.61

1.0

1.1

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.60

0.0

1.1

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

0.60

0.0

1.1

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

1.42

0.60

1.0

1.2

—

(37021550) Renin [Units/volume] in Plasma --upright

408

1.16

0.59

1.2

1.3

99.66

55.99

mu/l

1.19

289

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.55

0.57

1.0

1.2

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

127

896

0.90

0.57

1.1

1.2

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

246

0.80

0.57

2.0

17.53

17.97

umol/l

0.10

246

(3041184) Isoniazid [Presence] in Urine

1.65

0.56

3.2

2.6

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

178

1.24

0.55

2.2

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

247

1.20

0.55

2.3

2.7

0.60

0.55

u/field

0.10

247

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

1.37

0.55

1.4

1.5

1.15

1.91

mg/l

0.59

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

174

0.76

0.54

1.1

1.0

0.02

0.52

u/ml

1.16

112

(3006245) CD3-CD19+ cells/100 cells in Blood

100

560

1.13

0.54

1.6

2.1

8.47

10.30

0.85

506

(3028717) Thiamine [Mass/volume] in Blood

190

1.23

0.54

1.1

—

(3009677) Dengue virus Ab [Presence] in Serum

1.49

0.54

1.3

1.1

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

380

2265

1.06

0.53

1.1

10.35

11.01

au/ml

0.06

123

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

198

1153

1.09

0.52

1.7

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.54

0.52

1.1

1.0

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

485

1.13

0.52

1.1

1.3

137.28

131.30

nmol/l

0.10

344

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

515

0.87

0.51

1.5

0.47

0.36

ug/l

1.44

328

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1557

9582

1.03

0.51

1.2

119.31

141.08

iu/ml

1.38

590

3497

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

117

821

0.90

0.50

1.4

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

135

1.27

0.50

1.2

1.3

0.71

1.20

ml/s/173m2

1.63

(3051387) C reactive protein [Mass/volume] in Capillary blood

654

3963

1.04

0.50

4.4

3.2

25.82

27.75

mg/l

0.66

435

2428

(46236302) HLA-C [Type] by High resolution typing

0.64

0.50

1.0

—

(40760410) HLA-B [Type] by High resolution

0.64

0.50

1.0

—

(40760409) HLA-A [Type] by High resolution

0.64

0.50

1.0

—

(3013862) HLA-DP [Type]

0.62

0.49

1.0

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.69

0.49

1.6

1.5

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

197

1152

1.08

0.49

1.9

2.6

445.30

566.71

e6/l

2.05

158

981

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

1.53

0.49

1.0

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

1.51

0.48

1.0

1.3

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

145

838

1.09

0.47

1.3

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

194

1.21

0.47

1.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

147

851

1.09

0.46

1.6

—

(1761482) Bacteria [#/volume] in Urine by Culture

795

4848

1.04

0.46

4.9

3.8

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

436

1.13

0.46

1.1

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

466

1.13

0.46

1.4

1.3

2.06

3.08

umol/l

3.89

428

(3002719) Hemoglobin [Mass/volume] in Urine

1.43

0.46

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

781

4763

1.04

0.46

1.3

—

(3020393) Adenovirus Ag [Presence] in Stool

160

1.23

0.45

1.1

—

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

1.33

0.45

1.5

1.43

1.46

mg/l

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

1.33

0.45

1.5

1.61

3.79

mg/l

—

(3030313) Adrenal Ab [Titer] in Serum

1.33

0.45

1.1

1.0

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

1.33

0.45

1.5

3.12

2.08

mg/l

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

1.33

0.45

1.5

0.30

1.31

mg/l

1.52

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

1.33

0.45

1.5

1.80

2.13

mg/l

0.13

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

140

0.77

0.44

1.1

0.03

0.72

u/ml

—

107

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

100

570

1.11

0.44

1.6

2.1

31.44

30.33

0.24

530

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

104

0.73

0.44

1.1

1.2

1.32

1.41

0.47

104

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

161

940

1.08

0.43

1.0

1.1

10.17

9.83

iu/ml

0.06

210

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

125

0.76

0.43

1.7

1.9

—

(3015350) Toxocara sp Ab [Presence] in Serum

1.58

0.43

1.0

—

(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma

0.00

0.42

0.0

1.0

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

0.42

0.0

1.0

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

263

0.84

0.42

8.3

7.5

0.47

0.31

umol/l

1.19

240

(3005011) Chlamydia sp Ab [Titer] in Serum

208

0.82

0.42

1.8

1.7

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

478

0.89

0.41

1.1

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

1.51

0.41

1.6

1.1

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

330

0.86

0.41

1.0

1.1

5.92

8.57

u/ml

0.72

176

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

105

1.27

0.41

1.0

1.2

—

(40763590) HLA-DQ beta [Type]

0.65

0.40

1.0

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

1.38

0.40

1.1

1.0

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

934

5736

1.03

0.39

1.8

1.7

39.74

41.47

nmol/l

1.62

904

5573

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

137

0.78

0.39

1.0

1.1

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

235

1399

1.06

0.39

1.2

1.3

2.21

2.22

mmol/l

0.03

217

1302

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

442

2677

1.04

0.39

2.4

2.5

129.71

1045.42

u/ml

1.44

434

2647

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

261

1747

0.94

0.39

1.1

58.53

71.23

au/ml

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

382

0.88

0.39

1.6

1.4

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

540

3286

1.04

0.38

1.7

1.8

290.63

286.40

mu/l

0.07

489

3042

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

171

0.81

0.38

1.2

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

153

1.20

0.37

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

475

1.11

0.36

1.1

—

(3022475) Manganese [Moles/volume] in Blood

100

0.76

0.35

1.5

1.3

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

137

804

1.08

0.35

1.7

2.1

—

(3024316) Viscosity of Plasma

1.25

0.35

1.4

2.2

1.54

1.85

mpas

1.31

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

131

893

0.93

0.35

1.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

139

817

1.08

0.35

1.7

2.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

137

805

1.08

0.34

1.7

2.1

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

261

1.14

0.34

1.3

1.4

42.50

54.52

1.04

120

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

634

3884

1.03

0.33

1.3

1.4

16.37

32.57

e6/l

1.78

500

2950

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

208

1.16

0.33

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

120

703

1.08

0.33

1.2

1.1

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

1.31

0.33

1.3

1.2

—

(3007919) Fasciola sp Ab [Titer] in Serum

1.31

0.33

1.2

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

214

1.15

0.33

1.1

1.3

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

214

1.15

0.33

1.1

1.3

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

132

1.20

0.32

1.1

1.0

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

2509

15634

1.02

0.32

2.3

2.2

12.44

13.17

nmol/l

4.76

2222

14074

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

473

1.10

0.32

1.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

133

0.81

0.32

1.6

1.5

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

634

3890

1.03

0.31

1.3

1.5

1198.07

1907.83

e6/l

0.55

533

3115

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

480

1.09

0.31

1.1

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.30

0.31

1.0

1.1

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

1.23

0.30

1.6

1.5

0.58

0.79

umol/l

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

1.27

0.30

1.1

1.0

0.32

0.18

u/ml

—

(3041672) Baker's yeast Ab [Presence] in Serum

1.31

0.30

1.0

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

149

1003

0.94

0.30

1.2

1.4

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

1.35

0.29

1.0

1.1

—

mmol/l

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

0.72

0.29

1.1

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

320

0.89

0.29

1.1

0.31

0.94

u/ml

1.26

161

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

128

1.19

0.29

2.5

3.1

22.07

75.91

pmol/l

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

184

1103

1.06

0.28

1.9

2.7

0.22

0.24

e9/l

0.59

159

967

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

648

0.93

0.28

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

158

1.16

0.28

1.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

350

1.10

0.28

1.8

1.6

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

123

830

0.94

0.27

1.1

1.05

1.12

u/l

0.83

429

(3003577) Lead [Moles/volume] in Blood

130

0.83

0.27

1.4

1.5

0.34

0.16

umol/l

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

275

1813

0.96

0.27

1.4

1.6

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

1.27

0.27

1.0

49.00

24.57

u/ml

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

1.27

0.27

1.0

33.00

22.00

u/ml

—

(3025577) Chromium [Mass/volume] in Blood

213

1285

1.05

0.26

2.1

2.93

2.34

ug/l

0.68

180

1069

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

165

1.15

0.26

1.1

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

214

1.12

0.24

1.1

1.3

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

457

1.08

0.24

2.9

7.54

7.60

mg/l

0.03

368

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

269

1.11

0.24

1.1

1.3

34.86

44.35

mg/l

0.68

231

(3000060) B lymphocytes [#/volume] in Blood

400

0.92

0.23

1.7

2.0

493.93

1302.89

e6/l

0.53

204

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

1.32

0.23

1.4

1.2

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

197

1.12

0.23

1.5

1.4

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

221

0.89

0.23

1.3

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

355

1.09

0.22

1.1

1.2

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.22

0.0

1.1

—

(3026868) Penicillium brevicompactum IgE Ab [Units/volume] in Serum

0.00

0.22

0.0

1.3

—

(3012932) Hazelnut IgE Ab [Units/volume] in Serum

0.00

0.22

0.0

1.0

—

4.26

—

(3029889) Paecilomyces variottii IgE Ab [Units/volume] in Serum

0.00

0.22

0.0

1.3

—

(3014257) Rhodotorula spp IgE Ab [Units/volume] in Serum

0.00

0.22

0.0

1.3

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

307

1879

1.03

0.21

1.9

2.0

536.00

3997.91

titre

—

115

(3029612) Listeria sp Ab [Titer] in Serum

0.00

0.21

0.0

1.1

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

1.27

0.20

1.2

1.1

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

0.80

0.20

1.1

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

116

773

0.95

0.20

1.0

1.1

5.56

5.90

u/ml

0.05

110

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

254

1.10

0.20

1.5

1.4

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

350

0.92

0.20

2.1

1.7

2.01

2.51

ug/l

0.85

210

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

707

4388

1.02

0.19

2.6

3.6

1585.13

638.72

u/ml

0.54

647

3982

(3025886) Oxalate [Mass/time] in 24 hour Urine

1.17

0.18

1.0

1.1

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

129

1.13

0.17

2.0

2.1

16.87

20.95

mg/l

0.77

121

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

111

1.14

0.17

1.5

1.3

—

(3020650) Glucose [Presence] in Urine

411

1.06

0.16

1.3

1.4

—

(1002224) Polysomnography panel

1112

7124

0.99

0.16

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

302

1862

1.03

0.15

1.3

—

(3026470) Cobalt [Mass/volume] in Blood

217

1332

1.03

0.15

2.0

5.06

3.53

ug/l

1.01

197

1220

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

283

1.07

0.15

1.2

1.1

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

1.09

0.15

1.1

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

106

642

1.04

0.14

1.4

1.6

2.04

2.03

umol/l

0.00

101

600

(3021162) Amylase [Enzymatic activity/volume] in Specimen

370

0.94

0.14

2.7

2.9

675.35

1932.51

u/l

1.16

328

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

128

0.89

0.14

1.1

1.0

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

715

4457

1.01

0.14

1.3

580.98

579.71

mg/l

0.01

671

4237

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

125

1.11

0.14

2.0

2.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

226

0.92

0.13

1.0

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.13

0.13

1.5

1.6

—

(21494815) CD4 cells/100 lymphocytes in Specimen

248

1530

1.03

0.13

1.9

2.2

40.12

36.29

3.45

240

1500

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.17

0.13

1.0

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

575

0.96

0.13

2.3

3.2

—

(40758292) HTLV I+II Ab panel - Serum

310

0.94

0.13

1.3

1.5

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

630

3927

1.01

0.13

1.2

1.3

4.15

3.78

mmol/l

9.02

581

3692

(3019225) pH of Specimen

3139

19973

0.99

0.12

5.7

4.0

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

199

0.92

0.12

1.2

1.1

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

107

0.89

0.12

1.3

1.2

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

0.87

0.12

1.0

1.6

—

(4212803) Bone marrow aspirate examination

188

1.08

0.11

1.0

1.1

—

(3051101) Glucose [Moles/volume] in Cord blood

347

0.95

0.11

6.4

6.1

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

334

0.95

0.11

1.0

—

(3018291) Platelet Ab [Presence] in Serum

1.13

0.10

1.0

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

177

0.93

0.09

1.1

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

240

1489

1.02

0.09

1.0

730.93

736.28

ng/l

0.06

158

1028

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

166

1075

0.98

0.09

1.1

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

0.88

0.09

1.0

0.01

0.18

u/ml

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

441

0.96

0.09

1.1

—

(3013762) Body weight Measured

1.13

0.09

1.1

1.2

—

(3011325) HIV 1+2 Ab [Presence] in Serum

1.13

0.09

1.0

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

170

0.93

0.09

1.0

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

215

0.94

0.09

1.0

1.1

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

240

1491

1.02

0.08

1.0

39.84

43.27

ng/l

0.50

157

1057

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

0.81

0.08

1.2

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

234

0.95

0.08

1.1

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

124

0.92

0.08

1.1

14.43

14.59

nmol/l

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1196

7512

1.01

0.08

2.8

3.6

3004.41

1088.78

u/ml

0.40

1004

6491

(3029396) Erythrocyte agglutination [Presence] in Blood

1.10

0.08

1.4

1.9

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

421

1.04

0.08

2.6

2.4

193.75

181.79

au/ml

0.07

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

238

1480

1.02

0.08

1.0

290.08

353.29

ng/l

1.43

157

1064

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

182

0.94

0.08

4.8

5.5

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

1.05

0.08

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

123

1.08

0.08

1.0

—

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

1.07

0.07

1.1

1.0

2.65

0.30

u/ml

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

1.12

0.07

1.1

1.0

—

(3001556) Androgen free Index in Serum or Plasma

0.87

0.07

1.4

1.3

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

143

1.06

0.06

1.2

1.1

—

(40765096) Chromosome analysis panel by Banding

602

0.98

0.06

1.1

1.2

—

(3017732) Neutrophils [#/volume] in Blood

2005

12635

1.00

0.05

3.3

3.0

5.96

4.90

e9/l

1.91

1579

9768

(3036048) Francisella tularensis Ab [Titer] in Serum

425

1.03

0.05

1.2

808.00

653.33

titre

—

(3033942) Copper [Moles/time] in 24 hour Urine

1.10

0.05

1.1

0.52

0.74

umol/24h

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.08

0.05

1.3

1.1

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

113

1.06

0.04

1.6

1.3

310.63

355.50

umol/24h

0.56

113

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

159

0.95

0.04

1.6

1.7

1.54

1.66

mg/l

0.20

125

(40762814) Titanium [Mass/volume] in Blood

395

0.98

0.04

2.4

2.3

3.23

3.82

ug/l

0.67

138

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

1.07

0.03

1.1

1.3

1.00

1.08

u/field

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

160

1023

0.99

0.03

1.1

—

(3017509) Phencyclidine [Presence] in Urine

120

0.95

0.03

1.2

1.4

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

184

1175

0.99

0.03

1.2

40.94

48.13

mg/l

1.36

144

985

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

167

1046

1.01

0.03

1.1

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

208

1326

0.99

0.02

2.1

2.6

613.72

659.99

e6/l

0.31

192

1279

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

202

0.97

0.02

5.1

2.7

1.16

0.96

mg/l

0.62

140

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

310

0.98

0.02

1.1

1.2

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

290

0.98

0.01

1.2

1.1

—

(40768441) Liver Pathology biopsy report

222

1397

1.01

0.01

1.4

1.3

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

211

1.02

0.00

12.8

7.3

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.94

0.00

1.4

1.3

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

0.98

0.00

1.0

1.7

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.03

0.00

1.0

—

(3036180) Methadone [Presence] in Urine

491

1.00

0.00

2.2

2.0

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

125

794

1.00

0.00

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

279

1.00

0.00

1.4

2.3

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

145

1.00

0.00

2.3

2.7

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

0.98

0.00

1.0

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

178

1126

1.00

0.00

1.1

297.15

319.75

mg/l

0.55

146

994

(3018001) Oat IgE Ab [Units/volume] in Serum

1.03

0.00

1.1

0.09

0.29

u/ml

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

226

1.01

0.00

1.1

—

(3017501) Neutrophils [#/volume] in Blood by Manual count

0.00

-0.00

0.0

1.3

—

(3045759) Histamine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.0

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.99

-0.00

1.3

1.4

434.33

547.38

nmol/l

—

(3010937) Rubella virus Ab [Presence] in Serum

0.92

-0.00

1.1

1.0

—

(3006392) Corynebacterium diphtheriae [Presence] in Specimen by Organism specific culture

0.00

-0.00

0.0

1.0

—

(3035153) Lemon IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.2

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.6

—

Mortality – FinRegistry

↥

Association

Association between endpoint I9_CORATHER and mortality.

Females

Parameter	HR [95% CI]	p-value
I9_CORATHER	1.931 [1.79, 2.09]	< 0.001
Birth year	0.987 [0.98, 1.0]	0.001

During the follow-up period (1.1.1998 — 31.12.2019), 89079 out of 166934 females with I9_CORATHER died.

Males

Parameter	HR [95% CI]	p-value
I9_CORATHER	1.649 [1.53, 1.78]	< 0.001
Birth year	0.987 [0.98, 0.99]	0.001

During the follow-up period (1.1.1998 — 31.12.2019), 96810 out of 219429 males with I9_CORATHER died.

Mortality risk

Mortality risk for people of age

years, who have I9_CORATHER.

N-year risk	Females	Males
1	0.111%	0.214%
5	0.798%	1.488%
10	2.045%	3.61%
15	3.793%	7.058%
20	6.181%	11.9%

Relationships between endpoints

↥

Index endpoint: I9_CORATHER – Coronary atherosclerosis

GWS hits: 148

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Coronary atherosclerosis

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints